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The purpose of this Ph.D. research is to investigate and improve two classes of 
hydroxyapatite (HA)-based biomaterials for bone repair: calcium phosphate microspheres 
and bioactive silicate glass scaffolds. These biomaterials were prepared with modified 
compositions and microstructures and then were evaluated for bone regeneration. 
The open HA microspheres with dense convex surfaces and rough and porous 
concave surfaces were obtained by sectioning closed hollow HA microspheres. Bone 
regeneration with the open HA microspheres was greater than with the closed HA 
microsphere at 12 weeks. Hollow biphasic calcium phosphate (BCP) microspheres have 
been prepared with different fractions of HA and β-TCP (tricalcium phosphate) and their 
in vitro and in vivo reactivities determined. The BCP microspheres with higher -
TCP/HA ratio (70/30) had faster degradation rates both in vitro and in vivo and a better 
capacity to regenerate bone. Moreover, the more reactive BCP microspheres were 
associated with significantly more blood vessel formation in the subcutaneous implants.  
13-93 glass scaffolds with curved filaments stimulated a greater amount of new 
bone formation than straight filament scaffolds in rat calvarial defect at six weeks. 
Scaffolds with thin (6 ± 1 µm) HA-like surface layers were more effective at stimulating 
new bone formation, with the curved-filament structures again showing significant 
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1.1. THE NEED FOR IMPROVED SYNTHETIC BONE GRAFTS 
Effective regeneration of bone defects caused by trauma or chronic disease is a 
significant clinical challenge. Over the past decades, researchers have investigated the 
mechanism of bone regeneration in order to develop better healing strategies [1-3]. Bone 
healing involves three primary stages: the early inflammatory stage, the repair stage, and 
the late remodeling stage (Figure 1.1) [4, 5]. These three stages are distinct but 
continuous. In the inflammatory stage, a hematoma forms and inflammatory cells 
infiltrate the bone resulting in the formation of granulation tissue, vascular tissue and 
immature tissue. During the repair stage, new blood vessels are developed to extend 
tissue regeneration and growth; a soft callus is formed around the repair site, and then the 
soft callus converts to a hard callus. Bone healing is completed during the remodeling 
stage in which the bone is restored to its original shape, structure and mechanical 
strength. 
Bone defects are clinically reconstructed using treatments that rely on bone 
regeneration and augmentation. While various treatments have been investigated with 
encouraging results [6], complete and predictable bone reconstruction is often difficult to 
achieve[7]. Autologous bone grafts taken from intra- or extra-oral sites are the gold 
standard for treatment because they contain osteoinductive growth factors and osteogenic 
cells, and they provide a structural scaffold. However, disadvantages include limited 
  
2 
tissue availability, increased surgery time, and additional pain and cosmetic imperfection 
at the donor site [7-9]. Many of these issues can increase the health care cost for the 
patient [10]. An alternative to autogenous bone is allogenic bone that can induce 
moderate healing results due to its preserved osteoinductivity. However, allografts are 
costly, have unpredictable performance due to donor variance and adverse immune 
reactions, and they increase the risk of disease transference [11-13].Thus, there is a need 
to develop improved synthetic bone substitutes with good in vivo performance. 
 
 
Figure 1.1. Schematic of the 3 primary stages for bone fracture healing [5]. 
 
A number of bone graft substitute components are currently available. These 
include inorganic materials (calcium phosphate and calcium sulfates in ceramics, pellets, 
and injectable cements) and organic materials (demineralized bone matrix, bone 
morphogenetic proteins). In the current bone substitute market, calcium phosphates, 
bioactive glasses, and their combinations with polymeric materials, are among the most 
commonly available synthetic bone substitutes [14].  
  
3 
1.2. DEVELOPMENT OF THE GLASS CONVERSION TECHNIQUE 
Hench developed the first generation of bioactive glasses, including 45S5 
Bioglass® (45% SiO2, 24.5% Na2O, 24.5% CaO, and 6% P2O5 –weight %) [15]. He 
reported that a carbonate-substitute hydroxyapatite-like (HCA) layer formed on the 
surface of 45S5 in contact with the body fluid. A borate analog glass, designated 45S5B1, 
and having the same composition as 45S5 bioactive glass but with SiO2 replaced by 
B2O3, was investigated by Richard [16]. She found that a calcium phosphate layer formed 
on the glass surface after immersion in a K2HPO4 solution at 37°C; the calcium 
phosphate layer formed faster on 45S5B1 borate glass than on 45S5 glass. Fears [17] and 
Han [18] studied the reaction of glass spheres made from lithium calcium borate glass 
and sodium calcium borate glass in 0.25 M phosphate solution at 37 °C,  and they 
reported the formation of hydroxyapatite.  
1.2.1. Kinetics and Mechanism of Glass Conversion. The formation of a 
calcium phosphate layer on the surface of a calcium-containing borate glass immersed in 
a phosphate solution results from a series of dissolution-precipitation reactions. Ca2+ ions 
are released from a dissolving glass to the aqueous solution and when the local solubility 
limit is exceeded, these ions react with the phosphate anions to precipitate calcium 
phosphate phases on the glass surface.  The initial precipitation products are often x-ray 
amorphous, with various Ca/P ratios depending on the experimental conditions, and so 
are classified as amorphous calcium phosphates (ACP) [15, 19, 20].  Figure 1.2 shows the 
solubility of different stable calcium phosphate phases as a function of pH [21, 22].  
Hydroxyapatite (HA) is the most stable calcium phosphate phase in the pH range of 
typical conversion processes (pH=9-12), although other calcium phosphates are stable in 
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acidic conditions, and will precipitate from solutions with greater salinity.  Figure 1.3 
shows the speciation of phosphate anions in aqueous solutions as a function of pH; 
H2PO4
- and HPO4
2- are the dominant anions in solutions with pH<10, and PO4
3- anions 
become increasingly significant in more alkaline solutions.  
 
 
Figure 1.2. The solubility of different stable calcium phosphate phases as a function of 
pH. (A) 3D version of the classical solubility phase diagrams for the ternary system 
Ca(OH)2–H3PO4–H2O. Bottom: solubility phase diagrams in two-dimensional graphs, 
showing two logarithms of the concentrations of (B) calcium and (C) orthophosphate ions 
as a function of the pH in solutions saturated with various salts [22].  
 
As the glass continues to dissolve, the calcium phosphate layer grows inward 





anions that have transported through the reaction layer from the aqueous solution. The 
reaction continues until the soluble borate glass is completely dissolved.  Figure 1.4 is a 
schematic diagram demonstrating the main steps in the conversion of a lithium-calcium- 
borate glass in a phosphate solution.  
 
 
Figure 1.3. Dependence of phosphate species in aqueous solutions on pH [23]. 
 
 
Figure 1.4. Schematic diagram presenting main steps in the conversion of calcium-
containing borate glass (Li-Ca-B glass as example) in phosphate solution.  
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The final product of conversion is a calcium phosphate phase which depends on 
the pH of the solution. In acidic solutions,  dicalcium phosphate dihydrate (DCPD, 
CaHPO4·2H2O) or dicalcium phosphate anhydride (DCPA, CaHPO4) can form [24], 
whereas in basic solutions, non- stoichiometric, calcium-deficient hydroxyapatite 
(CDHA, Ca10-x(HPO4)x(PO4)6-x(OH)2-x) can be produced [18, 20, 24]. Stoichiometric HA 
has PO4
3- anions, some of which are replaced by  HPO4
2- or other anions (e.g. CO3
2-) in 
CDHA [22]. Similar effects of solution pH on the precipitation of Ca-phosphate phases 
have been reported in other studies [25, 26].   
The kinetics and mechanism of the formation of the CDHA layer on borate glass 
have been investigated in several studies [27-31]. The kinetics of glass conversion is 
often evaluated using weight loss data. The weight loss of glass is taken as the difference 
between the initial (unreacted) mass of particles and the mass at time t [29, 32], with the 
fraction of reacted glass given by .  Several models, then, can be used to analyze (t), 
assuming spherical particles in aqueous solutions [33]. The contracting volume model 
(CVM) assumes a surface reaction-controlled mechanism where particles react with their 
surroundings, and as the reaction progresses, the unreacted material uniformly decreases 
in size. The kinetic equation for CVM is given as: 
𝑘𝑐𝑣𝑚𝑡 = 1 − (1 − 𝛼)
1/3                                                      (1) 
where  is the fraction of sample reacted in time t and kCVM is the CVM reaction rate 
constant.  The three-dimensional diffusion model assumes that the transformation 
reaction is limited by the diffusion of a species through a reaction product to the reaction 




𝑘𝐷𝑡 = [1 − (1 − 𝛼)
1/3]
2
                                                    (2) 
where kD is the diffusion model reaction rate constant. 
Huang, et al. [29, 34] studied the effect of partially or fully replacing the SiO2 
content of 45S5 glass by B2O3 on the kinetics and mechanism of the conversion of glass 
particles to CDHA. Yao [30] did similar work for borate-substituted 13-93 glass particles. 
The conversion of particles of the borate analogue of 45S5 glass are well-described by a 
3D diffusion model over the entire reaction time, whereas the conversion of the 
borosilicate and silicate glasses was better described by a contracting volume model in 
the initial stage and by a 3D diffusion model in the later stages [31].  
Gu [27] studied the conversion of sodium calcium borate glasses to CDHA in 
0.25 M K2HPO4. CVM had a good fit for glass conversion at 10, 22 and 37 °C. At 70 °C, 
the early stage data followed a CVM, but the data was better fit by a diffusion model at 
the later stages. The activation energy for the conversion reaction in the 10~70°C range 
was 32~36 kJ/mol, which is similar to activation energies for hydration of borate 
minerals [35, 36], indicating that glass dissolution controls the conversion kinetics. 
George [37] investigated the conversion of 13-93B3 glass (12% K2O, 6% Na2O, 
20% CaO, 5% MgO, 53% B2O3 and 4% P2O5 wt %) to calcium phosphate in water at 21 
to 60 °C. The glass dissolution kinetics initially followed a reaction-controlled 
contracting volume model. As the glass dissolved, a Mg-substituted amorphous calcium 
phosphate layer precipitated on the glass surface. After the glass was ~25% reacted, the 
dissolution kinetics transitioned to follow a diffusion-controlled model. Both the 
reaction-controlled and diffusion-controlled kinetic reactions exhibited an Arrhenius 
relationship, with activation energies of ~32 and 41 kJ/mol, respectively, similar to those 
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reported by Gu [27]. The resulting amorphous calcium phosphate (ACP) layer had a 
greater Ca/P ratio than stoichiometric hydroxyapatite, which prevented the transition 
from ACP to HAp. 
 
Table 1.1. Factors that influence final product of calcium borate glass conversion in 
phosphate solution. 
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(0 < x < 1) 
6.5-9.5 - 
1.67 
HAp, or OHAp 
(Hydroxyapatite) 
Ca10(PO4)6(OH)2 9.5-12.0 3.155 
2.0 






a These compounds cannot be precipitated from aqueous solutions. 
b Always metastable. The composition of the precipitate depends on the composition and 
pH of the electrolyte solution. 




1.2.2. Parameters that Influence the Glass Conversion Reaction.  The 
microstructural features of the calcium phosphate microspheres produced by the borate 
glass conversion process depend on the process parameters (Table 1.1). Fears [17] 
investigated the effect of the calcium content of lithium calcium borate glass spheres on 
the reaction product formation in aqueous phosphate solutions. The thickness of the 
calcium phosphate shell wall increased with increasing Ca-content in the initial glass 
spheres. Glasses with ≤ 40 wt% CaO formed CDHA microspheres with a hollow core 
and mesoporous shell. Glasses with > 40 wt% CaO formed solid but porous CDHA 
microspheres. For the hollow microspheres, the ratio of the diameter of the hollow core 
(d) to the outer shell diameter of the microsphere (D) was affected by the concentration 
of the phosphate solution and the temperature in the system [20]. The d/D ratio decreased 
as the concentration of the phosphate solution or temperature increased. 
The composition of the converted product is affected by both the glass 
composition and solution chemistry, including the pH value. Huang [34] investigated the 
conversion of four-component borate glasses with the composition 10% Li2O, 10% CaO, 
10% AeO and 60% B2O3 (wt%) in an aqueous phosphate solution, where Ae is the 
alkaline earth element Mg or Ba. The reaction product after 30-50 hours was a calcium-
magnesium (or -barium) phosphate phase. For variations in solution chemistry, carbonate 
or fluoride substituted CDHA could be produced by adding carbonate or fluoride ions to 
the conversion solution [24, 38]. The formation of specific calcium phosphate phases 
depends upon the pH of the solution. The stability of calcium phosphate phases, at 
different pH values, has been studied previously (Table 1.2). Based on the stability of 
these calcium phosphate phases, Vanderspiegel [24] related the transformation of 
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potassium calcium borate glasses to specific crystalline calcium phosphate phases. By 
adjusting the pH of the conversion solution, these glasses produced three poorly-
crystallized calcium phosphate phases, including DCPD at pH≈4.4, DCPA at pH≈5.5, 
and CDHA at pH≈9.2.  
1.2.3. Hollow HA Microspheres.  As mentioned before, the hollow HA 
microsphere technology was developed at Missouri S&T to address the need for bone 
graft substitution materials [17, 20, 49, 50]. Glass microspheres with the composition of 
15CaO, 11Li2O,74B2O3 (wt%), designated CaLB3-15, were converted in 0.02 M 
K2HPO4 solution at 37 °C and pH = 9 [49] to form hollow CDHA microspheres with 
mesoporous shell walls, an example of which is shown in Figure 1.5.  
 
 
Figure 1.5. Hollow CDHA microspheres produced by glass conversion. (A) Optical 
image of starting glass (CaLB3-15) microspheres, and SEM images of (B) external 
surface of hollow CDHA microsphere prepared by converting the glass microspheres for 
48 h in 0.02M K2HPO4 solution at 37°C and pH = 9, (C) cross section of hollow CDHA 
microsphere [49].  
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As a synthetic bone graft, the hollow CDHA microspheres lack the osteogenic 
cells and osteoinductive growth factors present in autologous bone. However, hollow 
CDHA microspheres can be combined with growth factors to enhance bone regeneration. 
The hollow CDHA microspheres with high surface areas have been used as platforms for 
controlled delivery of proteins [49-52]. Previous work at Missouri S&T showed that 
hollow CDHA microspheres can absorb proteins like bovine serum albumin (BSA) [49], 
transforming growth factor-β (TGF-β) [50], and bone morphogenetic protein-2 (BMP-2) 
[52], and release these proteins in vitro or in vivo.  
Implantation of the hollow HA microspheres in rat calvarial defects in vivo 
stimulated  limited new bone formation at 6 weeks and 12 weeks, whereas first loading 
the hollow CDHA microspheres with TGF-β resulted in an improvement of new bone 
formation in rat calvarial defects at 6 weeks, but not at 12 weeks [50].The new bone in 
the implant with the microspheres loaded with TGF-β was only ~20% of the total defect 
area after 6 weeks or 12 weeks. The hollow CDHA microspheres loaded with BMP-2 (1 
g per defect) showed a significant increase in bone regeneration compared with the 
microspheres without BMP-2 at 6 weeks. Hollow CDHA microspheres coated with 
different thickness of poly(lactic-co-glycolic acid) (PLGA) delayed the release of BMP-2 
[52].  
Open CDHA microspheres are hollow CDHA microspheres (hereafter, called 
closed HA microspheres) that have been sectioned, as shown in Figure 5C. From the 
histological characterization of implants in rat calvarial defects, enhanced new bone 
growth was noted in the micro-concavity of open CDHA microspheres [52]. Previous 
work [53] showed that the open CDHA microspheres with exposed micro-concave 
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mesoporous hydroxyapatite in their cores promoted osteogenic differentiation of rat 
mesenchymal stem cells and increased alkaline phosphatase activity in vitro compared to 
closed CDHA microspheres. In the follow-up study [53], rat calvarial defects implanted 
with the CDHA microspheres containing 50% open CDHA microspheres showed 
considerable new bone formation in the many micro-concave regions of the open CDHA 
microspheres. The enhanced osteogenic property of open CDHA microspheres is 
presumably a result of their specific microgeometry.  
Although the hollow CDHA microspheres showed promising results in bone 
repair, the effectiveness of these open CDHA microspheres still needs to be improved to 
optimize bone regeneration. 
1.3. BIPHASIC CALCIUM PHOSPHATE 
Hydroxyapatite (HA, Ca10(PO4)6(OH)2) is widely used as a synthetic bone graft 
material for bone regeneration[22, 54, 55]. It is biocompatible and osteoconductive and 
produces no systemic toxicity or immunological reactions. Osteoblasts and osteoclasts 
adhere well to the surface of HA to form the cytoskeletal structure [56-59].  Moreover, 
HA forms a chemical bond between the implant and surrounding bone [60]. However, 
HA has found limited use as an implant material, principally because it lacks the 
osteoinductivity and osteogenicity possessed by allografts or autografts [1, 14, 61, 62]. In 
practice, mixing HA with osteogenic growth factors is often needed to achieve desirable 





Table 1.3. Commercial BCP products and weight ratios of composition phases [75]. 
-TCP% HA% Brand name 
<4 >96 Calciresorb (Ceraver, France) 
20 80 Osteosynt (Einco, Brazil) 
25 75 TCH (Kasios, France) 
30 70 
Ceratite (NGK Spark Plug, Japan) 
OrthoCer HA TCP (Baumer, Brazil) 
35 65 
CuriOs (Progentix Orthobiology BV, Netherlands) 
Ceraform (Teknimed, France) 
Calcicoat (Zimmer, IN) 
40 60 
BCP (Depuy Bioland, France) 
BCP BiCalPhos (Medtronic, MN) 
BonaGraft (Biotech One, Taiwan) 
BoneMedik-DM(Meta Biomed, Korea) 
CellCeram (Scaffdex Oy, Finland) 
GenPhos HA TCP (Baumer, Brazil) 
Graftys BCP (Graftys, France) 
Hatric (Arthrex, US) 
Hydros (Biomatlante SA, France) 
Kainos (Signus, Germany) 
MasterGraft Granules (Medtronic Sofamor Danek, 
US) 
MBCP (Biomatlante SA, France) 
OpteMx (Exactech, FL) 
Ossceram nano (Bredent Medical, Germany) 
Osteosynt (Einco, Brazil) 
Ostilit (Stryker Orthopaedics, NJ) 
SBS (ExpanScience, France) 
TriOsite (Zimmer, IN) 
4Bone (MIS, Israel) 
45 55 
CuriOs (Progentix Orthobiology BV, Netherlands) 
Eurocer (FH, France) 
50-70 30-50 Indost (Polystom, Russia) 
80 20 
BoneCeramic (Straumann, Switzerland) 
BoneSave (Stryker Orthopaedics, NJ) 
Kainos (Signus, Germany) 
MBCP+ (Biomatlante SA, France) 
OsSatura BCP (Integra Orthobiologics, CA) 
Osteosynt (Einco, Brazil) 
ReproBone (Ceramisys, UK) 
Tribone 80 (Stryker, Europe) 
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Tricalcium phosphate (-TCP, Ca3(PO4)2), also known as bone ash, is a source for 
calcium and phosphorus, which can be easily assimilated and absorbed by the body. -
TCP is also widely used in calcium phosphate bone cements [63-65], and other types of 
bone-substitution bioceramics [66-68], including those for dental applications [69]. -
TCP is both osteoconductive and osteoinductive, and due to its low interfacial energy 
with respect to apatite, it can provoke the precipitation of an apatite layer upon incubation 
in aqueous ionic solutions [70]. β-TCP cannot be directly precipitated from aqueous 
solutions [22]; instead, it forms when other phases, like CDHA [71] or mixtures of 
materials like dicalcium phosphate anhydrous and CaO [72], are heated above about 
800°C. β-TCP can also be prepared at relatively low temperatures (~150 °C) by 
precipitation in water-free media, such as ethylene glycol [69]. 
In general, HA is poorly bioresorbable, whereas -TCP is more bioresorbable and 
can be replaced by new bone at faster rates [22, 48]. These properties mean that the rate 
of degradation and bioactivity of calcium phosphate implant materials can be tailored 
using biphasic calcium phosphate (BCP) materials with a range of -TCP-to-HA ratios 
[73, 74]. The in vivo dissolution/reprecipitation processes of BCP materials have been 
studied extensively by TEM [73, 74]. Their dissolution rates are  dependent on the -
TCP/HA ratio, and the microcrystals that form during reprecipitation have 
crystallographic properties and Ca/P ratios similar to those of bone apatite [74]. 
Moreover, the new apatite crystals are defined as carbonate-apatite [73]. 
BCP ceramics with various ratios of -TCP and HA are known to be effective and 
biocompatible scaffolds for tissue-engineering applications. The ratio between the more 
soluble -TCP and the more stable HA has been varied to adjust the level of bioactivity, 
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bioresorbability, osteoconductivity, and osteoinductivity [75-78]. BCPs may be produced 
by mixing HA and -TCP powders, or by sintering CDHAs at high temperature to 
produce mixtures of the two different phases[78].  
Although various BCP products with different -TCP/HA ratios have been 
evaluated in large number of studies, there seems to be no agreement about the optimal 
ratio of BCP phases for clinical applications [75].  Currently, there are over 30 
commercially available BCP bone substitute products for various orthopedic and 
maxillofacial applications. The commercial BCP products with relative -TCP/HA 
weight ratios are summarized in Table 1.3 [75].  
1.4. ADDITIVE MANUFACTURE OF BIOACTIVE GLASS SCAFFOLDS 
Bioactive glasses are widely used as scaffold materials for bone repair, due to 
their biocompatibility, osteoconductivity, their ability to form hydroxyapatite (HA) -like 
layers in vivo, and their ability to form a strong bond with the host bone. By adjusting the 
composition, a bioactive glass can release certain elements, such as boron [79], zinc [80, 
81], copper [82, 83], and strontium [84], in a controlled manner that facilitates bone 
regeneration. Bioactive silicate glasses, including 45S5 [85, 86] and 13-93  [87-89], have 
been approved by the Food and Drug Administration (FDA) for in vivo use, and scaffolds 
based on these bioactive glasses can be fabricated with different architectures to provide 
desired mechanical and chemical environments for bone reconstruction. 13-93 (53SiO2, 
6Na2O, 12K2O, 5MgO, 20CaO, 4P2O5, wt%) is a bioactive glass that is more stable 
against crystallization than is 45S5 [90, 91], and so has been used in applications that 
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require heat treatments to consolidate glass particles or to create bonds between structural 
elements by viscous flow  [92-95]. 
Additive manufacturing techniques have led to innovative design and control of 
scaffold architectures [96]. At Missouri S&T, porous bioactive glass scaffolds have been 
fabricated using different manufacturing techniques, their in vitro mechanical properties 
have been characterized, and their ability to support bone infiltration in vivo has been 
evaluated. Mechanically strong porous scaffolds of 13-93 bioactive glass were created 
using a freeze extrusion fabrication (FEF) technique [94, 97]. Subsequently, the 
robocasting process was used to manufacture scaffolds from 13-93 bioactive glass [92, 
98, 99]. 
Scaffolds with a grid-like microstructures (Figure 1.6), produced by robocasting 
13-93 bioactive glass, promote the formation of new bone in rat calvarial defects. 
Pretreatment of these glass scaffolds in a phosphate solution to convert a thin surface 
layer of glass (~ 5 μm) to amorphous calcium phosphate or Ca-deficient hydroxyapatite 
prior to implantation, significantly enhances the capacity of the scaffold in bone 
regeneration [99]. Compared with other architectures of scaffolds made with the same 
glass composition (Table 1.4), these results indicated that the grid-like architecture has a 
better capacity to support bone regeneration than the oriented, trabecular and fibrous 
structures. By loading the surface modified scaffold with BMP-2 (1 μg per defect), new 
bone regeneration that infiltrated the scaffold significantly increased to 60% at six weeks 




Figure 1.6. SEM images of silicate 13-93 bioactive glass scaffolds prepared by robotic 
deposition (robocasting): (a) plane of deposition (xy plane); (b) perpendicular to the 
deposition plane (z direction) [92]. 
 
Table 1.4.  Comparison of new bone formed in scaffolds composed of silicate 13-93 glass 
with different microstructures after implantation in rat calvarial defects (4.0-4.6 mm in 














Grid-like 47 300300150 32 ± 13 18 ± 8 6 [99] 
Trabecular 80 100-500 25 ± 12 19 ± 9 12 [100] 
Oriented 50 100-150 37 ± 8 18 ± 3 12 [100] 
Fibrous 50 50-500 ~17a 8.5 ± 2 12 [101] 
The amount of new bone is shown as a percent of the available pore space (area) in the 
scaffolds and the total defect area. 
a Estimated from the total defect area. 
 
Although the porous scaffolds of 13-93 bioactive glass with modified surfaces 
were promising in healing bone defects in vivo, the ability to regenerate bone still needs 
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to be improved. Since the architecture of the glass scaffold plays an important role in 
bone repair, optimization of these structures, made possible by additive manufacturing 
techniques, may enhance the bone regeneration. 
Rumpler et al [38] described curvature-driven effects that promoted in vivo tissue 
formation in scaffolds, particularly on concave surfaces, and Paris et al. [19] developed a 
scaffold curvature-mediated mechanism for the in vivo bio-mineralization of extra-
cellular matrix. An in vivo test showed that concavities stimulated the formation of blood 
vessels which play an important role in bone regeneration [102]. Bone formation by 
intramembranous ossification was preferred on a concave surface [103], and concavity 
was shown to be conducive to the accumulation of growth factors, such as bone 
morphogenetic proteins (BMPs) [104]. Based on these results, the addition of concave 
structures into the design and fabrication of 13-93 glass scaffolds may have a positive 
effect on bone regeneration.  
In the end, it is clear that the microstructures and compositions of the materials 
used for synthetic bone graft are significant factors for bone repair. Novel materials, like 
those derived from the glass dissolution/precipitation process, and additive manufacturing 
techniques like robocasting, provide researchers with new opportunities to optimize those 





2. RESEARCH OBJECTIVE 
 
The objective of this study is to investigate and improve two classes of 
hydroxyapatite-based biomaterials for bone repair: 1) hollow calcium phosphate 
microspheres with different microstructures and compositions, and 2) bioactive silicate 
glass (13-93) scaffolds with different architectures to promote bone regeneration. 
A considerable amount of new bone growth in the micro-concavity of open HA 
microspheres was observed in previous work at Missouri S&T [52, 53]. As open HA 
microspheres can be systematically obtained by sectioning closed HA microspheres, we 
hypothesize that open HA microspheres with special characteristics can improve bone 
regeneration compared to the closed HA microspheres. One goal of this study is to 
investigate the dependence of microgeometry, size, and time on bone regeneration in an 
osseous model, and then to evaluate the capacity of open HA microspheres loaded with 
BMP-2 for bone regeneration in a rat calvarial defect model.  
Additionally, previous studies [38, 50, 52] have shown that the hollow CDHA 
microspheres alone have limited capacity for bone regeneration, likely because of their 
chemical stability.  In the present study, hollow BCP microspheres are described, 
produced by heat-treating CDHA microspheres prepared using the glass conversion 
technique. The degradation rates and performance in vitro and in vivo are evaluated. 
Finally, considering the effects of scaffold architecture on bone regeneration, we 
hypothesized that 13-93 glass scaffolds with curved filaments, produced by the 
robocasting technique, may have improved capability to regenerate bone in vivo. Some  
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scaffolds were pre-reacted in a phosphate solution to form a thin HA-like layer, prior to 
implantation and the capability of 13-93 glass scaffolds with curved filaments to facilitate 





I. EVALUATION OF OPEN HOLLOW CDHA MICROSPHERES ON BONE 
REGENERATION IN RAT CALVARIAL DEFECTS 
 
Youqu Shen1, Mohamed Rahaman1, Yongxian Liu1, Yue-Wern Huang2 
1Department of Materials Science and Engineering, Missouri University of Science and 
Technology Rolla, MO, 65409 
2Department of Biological Sciences, Missouri University of Science and Technology 
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ABSTRACT 
Hollow Ca-deficient hydroxyapatite (CDHA) microspheres facilitate bone 
regeneration in rats with non-healing calvarial defects. Open CDHA microspheres were 
obtained by sectioning closed hollow CDHA microspheres. The open CDHA 
microsphere had dense outer (convex) surfaces and rough and porous inner (concave) 
surfaces. For both size ranges (ϕ106-150 μm vs. ϕ212-250 μm), the open CDHA 
microsphere were more effective in facilitating bone regeneration than the closed CDHA 
microspheres in rat calvarial defects. After twelve weeks, bone regeneration in the open 
CDHA microspheres (49 ± 7% for ϕ106-150 μm; 40 ± 8% for ϕ212-250 μm) was greater 
than the closed CDHA microspherse (26 ± 8% for ϕ106-150 μm; 30 ± 9% for ϕ212-250 
μm). Furthermore, the smaller open CDHA microspheres showed a significant increase in 
bone regeneration over the larger open CDHA microspheres at both 6 weeks and 12 
weeks. The difference in bone regeneration between these microspheres may be due to 
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their differences in microstructures, namely curvature, concavity, porosity, surface 




Effective regeneration of bone defects caused by trauma or chronic diseases is a 
significant clinical challenge. Over the past few decades, researchers have investigated 
the mechanism of bone regeneration to better inform the designs of healing strategies [1-
3]. Bone healing involves three primary stages: the early inflammatory stage; the repair 
stage and the late remodeling stage [4]. These three stages are distinct, but continuous. In 
the inflammatory stage, a hematoma forms and inflammatory cells infiltrate the bone, 
resulting in the formation of granulation tissue, vascular tissue and immature tissue. 
During the repair stage, new blood vessels are developed to facilitate tissue regeneration 
and a soft callus is formed around the repair site. Bone healing is completed during the 
remodeling stage in which the bone is restored to its original shape, structure and 
mechanical strength. 
Clinically, bone deficiency is overcome using treatments that rely on bone 
regeneration and augmentation. While various treatments have been investigated with 
encouraging results [5], complete and predictable bone reconstruction is often difficult 
[6]. Autologous bone grafts are the gold standard for treatment because they contain 
osteoinductive growth factors, osteogenic cells and a structural scaffold. However, 
disadvantages of this treatment include limited tissue availability, increased surgery time, 
additional pain and cosmetic imperfection at the donor site [6-8]. Many of these issues 
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can increase the health care cost for the patient [9]. An alternative to autogenous bone is 
allogenic bone, which can induce moderate healing results due to its preserved 
osteoinductivity. However, allografts are costly, can have unpredictable effects on growth 
due to donor variance, cause adverse immune reactions, and increase the risk of disease 
transference [10-12]. Synthetic bone grafts have advantages such as consistent quality, 
safety, and good tissue tolerance, but they usually function as inert or merely 
osteoconductive implants. Encouraging results have been reported.  
Hydroxyapatite (HA), the main component and essential ingredient of human 
bone, can be prepared by various methods. Studies have demonstrated that HA supports 
bone regeneration and bonding to surrounding tissue because of its biocompatibility, 
bioactivity, and osteoconductivity [13]. Closed hollow microspheres composed of Ca-
deficient hydroxyapatite (CDHA) can be produced using the glass conversion technique 
[14]. Previous studies showed that closed CDHA microspheres promoted the 
regeneration of bone in non-healing rat calvarial defects [15, 16], and that the mechanical 
properties and biological response depended on the microsphere size (ϕ106-150 𝜇m and 
ϕ150-250 𝜇m) [17]. In these in vivo tests, it was occasionally observed that better bone 
regeneration was associated with broken microspheres with exposed micro-concavity [16, 
18], and this observation is the motivation for the present study, to see more 
systematically if  open CDHA microsphere with particular geometric characteristics can 
yield better bone regeneration compared with the closed CDHA microspheres. Closed 
and open CDHA microspheres with two size ranges (ϕ106-150 μm and ϕ212-250 μm) of 




2. MATERIALS AND METHODS 
2.1. PREPARATION OF CLOSED AND OPEN CDHA MICROSPHERES  
The closed hollow CDHA microspheres were prepared by conversion of solid 
glass microspheres in an aqueous phosphate solution, as described in a previous study 
[14]. Briefly, calcium-lithium-borate glass with the composition of 15CaO, 11Li2O and 
74B2O3 (wt%), designated as CaLB3-15, was prepared by melting CaCO3, Li2CO3, and 
H3BO3 (Alfa Aesar, Haverhill, MA, USA) in a platinum crucible at 1200 °C for 45 min 
and then quenching the melt between stainless steel plates. Glass particles were obtained 
by grinding the glass using a a mortar and pestle, crushing the powder in a shatter box, 
and sieving through 100 and 140 mesh (US standard) sieves for the ϕ106-150 μm size 
range, or 60 and 70 mesh sieves for the ϕ212-250 μm size range. Glass microspheres 
were obtained by dropping the particles down through a vertical furnace at 1200 °C. The 
closed hollow hydroxyapatite microspheres were obtained by reacting the glass 
microspheres in a 0.02 M K2HPO4 solution at 37 °C and pH = 9 for 7 days. In the 
conversion process, 1 g glass was immersed in a 200 ml phosphate solution and the 
system was stirred gently and continuously. The converted microspheres were washed 
with distilled water and anhydrous ethanol, and then dried at room temperature for at 
least 12 h, and at 90 °C for at least 12 h. 
The open CDHA microspheres were obtained by sectioning the closed hollow 
CDHA microspheres using a microtome. Briefly, the closed CDHA microspheres were 
fixed on a wax block using a water-soluble tape and were sectioned by microtome. The 
open CDHA microspheres were washed with distilled water and ethanol, and then dried 
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at room temperature for at least 12 h, and at 90 °C for at least 12 h. Any debris left in the 
open CDHA microspheres after sectioning was removed using sieves.  
2.2. CHARACTERIZATION OF CLOSED AND OPEN CDHA MICROSPHERES 
The microstructures of the closed and open CDHA microspheres were observed 
using a scanning electron microscope (SEM; S4700 Hitachi, Tokyo, Japan) with an 
accelerating voltage of 15kV and working distance at 12 mm, and compositions were 
determined using energy dispersive X-ray (EDS) with an electron beam spot size of 1 
μm.  
The specific surface area (SSA) of the closed and open CDHA microspheres and 
pore size distributions of the shell walls were measured using nitrogen absorption 
(Autosorb-1; Quantachrome, Boynton Beach, FL) as described in a previous study [14]. 
Three hundred milligrams of closed or open CDHA microspheres were weighed and 
evacuated at 120 °C for 15 h to remove absorbed moisture. The volumes of nitrogen 
absorbed and desorbed at different relative gas pressures were measured and used to 
construct adsorption-desorption isotherms. The first twelve points of the adsorption 
isotherm, which initially followed a linear trend implying monolayer formation of 
adsorbate, were fitted to the Brunauer-Emmett-Teller equation to determine the specific 
surface area. The pore size distributions of the shell wall of the hollow CDHA 
microspheres were calculated using the Barrett-Joiner-Halenda method applied to the 
deposition isotherms [19].  
  
27 
2.3. ANIMALS AND SURGICAL PROCEDURES 
All animal use and care procedures were approved by the Missouri S&T 
Institutional Animal Care and Use Committee in compliance with the NIH Guide for 
Care and Use of Laboratory Animals (1985). The rat calvarial defects were implanted 
with four groups of implants composed of closed or open hollow CDHA microspheres 
for 6 weeks and 12 weeks (Table 1). The implantation time was based upon considerable 
bone regeneration in rat calvarial defects implanted with hollow CDHA microspheres 
observed in previous studies [15, 16]. Closed or open CDHA microspheres in the two 
size ranges were randomly implanted into defect areas, but mixing implants of closed and 
open microspheres in the same animal was avoided due to the possible migration of low-
weight open CDHA microspheres. 
 
Table 1. Implants groups composed of closed or open hollow CDHA microspheres. 
Group CDHA microspheres 
Sample size (n) 
6 weeks 12 weeks 
1 
106-150 µm 
Closed 5 5 
2 Open 5 5 
3 
212-250 µm 
Closed 5 10 
4 Open 5 10 
 
The male Sprague-Dawley rats (3 months old, weight = 350 ± 30 g, Envigo, 
USA) were acclimated for 2 weeks to diet, water, and housing under a 12 h/12 h 
light/dark cycle. The rats were anesthetized with a combination of ketamine and xylene 
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(0.15 μl per 100 g) and maintained under anesthesia with isoflurane in oxygen. The 
surgery area on each animal was shaved, scrubbed with 70% ethanol and iodine, and then 
draped. With sterile instruments and using an aseptic technique, a 1 cm cranial skin 
incision was made in an anterior to posterior direction along the midline. The 
subcutaneous tissue, musculature and periosteum were dissected and reflected to expose 
the calvaria. Bilateral full thickness defects (4.6 mm in diameter) were created in the 
central area of each parietal bone using a saline-cooled trephine drill. The sites were 
constantly irrigated with sterile PBS to prevent overheating of the bone margins and to 
remove the bone debris. Each defect was randomly implanted with the CDHA 
microspheres from the four diffeent groups. After implantation, one drop of Ringer’s 
solution was added to each defect. The periosteum and skin were repositioned and closed 
with wound clips. Each animal received an intramuscular injection of ~200 μl 
buprenorphine and ~200 μl penicillin post-surgery. All animals were monitored daily for 
the condition of the surgical wound, food intake, activity and clinical signs of infection. 
After 6 or 12 weeks, the animals were sacrificed by CO2 inhalation, and the calvarial 
defect sites with surrounding bone and soft tissue were harvested for subsequent 
evaluations. 
2.4. HISTOLOGICAL PROCESSING 
Harvested calvarial samples were fixed in a 10% formaldehyde solution for five 
days. The samples were cut into half after being washed with deionized water. Half of the 
sample was for paraffin embedding, and the other half was for poly (methyl 
methacrylate) (PMMA) embedding. The paraffin-embedded samples were decalcified in 
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14 wt% ethylenediaminetetraacetic acid (EDTA, Sigma-Aldrich, USA) for 2 weeks, 
dehydrated in ethanol, and then embedded in paraffin using standard histological 
techniques. These samples were sectioned using a microtome. The thickness of the tissue 
section with paraffin was 5 μm. These slices were then stained with hematoxylin and 
eosin (H&E) [20]. Without decalcification, the samples for PMMA embedding were 
dehydrated in ethanol and embedded in PMMA. These samples were sectioned, affixed to 
acrylic slices, and ground to a thickness down to 50 μm using a micro-grinding system 
(EXAKT 400CS, Norderstedt, Germany). The von Kossa staining was used to observe 
mineralization [21]. 
2.5. HISTOMORPHOMETRIC ANALYSIS 
Histomorphometric analysis was carried out using optical images of stained 
sections and Image J software (National Institutes of Health, USA). The percentage of 
new bone formed in a calvarial defect was evaluated from the H&E stained sections. The 
newly formed bone was identified by outlining the edge of the defect, with the presence 
of old and new bone being identified by lamellar and woven bone, respectively. The total 
defect area was measured from one edge of the old calvarial bone, including the entire 
implant and tissue within it, to the other edge of the old bone. The newly formed bone 
within this area was then outlined and measured; the amount of the new bone was 
expressed as a percentage of the total defect area. The amount of von Kossa positive area 
is shown as a percent of the total defect area. 
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2.6.  STATISTICAL ANALYSIS 
Measurements of the percentage of new bone (relative to the entire defect area) 
are expressed as a mean ± SD. Analysis for differences between groups was performed 
using one-way analysis of variance (ANOVA) followed by the Tukey’s post hoc test; the 
differences were considered significant at p < 0.05.  
 
3. RESULTS 
3.1. GEOMETRY OF THE CLOSED AND OPEN CDHA MICROSPHERES 
The closed CDHA microspheres were prepared by converting glass microspheres 
in a phosphate solution. The diameters of the starting glass microspheres were either 
ϕ106-150 μm or ϕ212-250 μm. After conversion, changes in the diameter of the 
microspheres were negligible. The SEM images revealed a spherical shape for the closed 
CDHA microspheres with two size ranges: ϕ106-150 μm (hereafter, small size; Figure 
1A1 and A2) and ϕ212-250 μm (thereafter, large size; Figure 1C1 and C2). Open CDHA 
microspheres were sectioned from closed CDHA microspheres using a microtone. The 
SEM images confirmed successful formation of hemispherical open CDHA microspheres 
with both sizes (Figure 1B1, B2, D1 and D2). The hollow microspheres have a hollow 
core with a diameter of about 60% of the overall microsphere diameter. The shell wall 
consists of two distinct layers: a denser external layer, about ~ 5 μm thick, and a more 
porous internal layer. Figure 2 shows representative high-resolution images of the inner 
and outer surfaces of open microspheres.  The outer surfaces consist of uniform 
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distributions of nanoparticles, and the inner surfaces appear to have rougher 
agglomerations of similar nanoparticles.  
 
 
Figure 1. SEM images of 106-150 μm closed CDHA microspheres (A1, A2) and open 
CDHA microspheres (B1, B2) and 212-250 μm closed CDHA microspheres (C1, C2) and 








Figure 2. SEM images of an external surface (A) and internal surface (B) from a 106-150 
μm open CDHA microsphere, and an external surface (C) and internal surface (D) of a 
212-250 μm open CDHA microsphere. 
 
Table 2. Surface area and average pore size of closed 106-150 μm and 212-250μm 
CDHA microspheres. 
HA microspheres Surface area (m2/g) Average pore size (nm) 
106-150 µm 101 13 
212-250 µm 168 10 
 
The BET surface area and average pore size of the two sets of closed CDHA 
microspheres are summarized in Table 2. The surface areas of small and large closed 
CDHA microspheres were 101 m2/g and 168 m2/g, respectively. The average pore sizes 





surface area was greater in the large CDHA microspheres, whereas the average pore size 
was greater in the small CDHA microspheres. 
3.2.  COMPOSITION OF THE CLOSED AND OPEN CDHA MICROSPHERES 
 
 
Figure 3. X-ray diffraction pattern of CDHA microspheres prepared by glass conversion 
technique. The pattern of a reference hydroxyapatite (HA, 01-076-0694) is also shown. 
 
The board peak in XRD pattern of CDHA (Figure 3) indicated that the materials 
is poorly crystallized, or nanocrystal, or a combination of both. High-resolution cross-
sectional SEM images of representative hollow CDHA microspheres are shown in Figure 
4. The shell walls of the microspheres were divided into three regions: external layer, 
middle layer and inner layer. The Ca/P atomic ratio at the midpoint of each region was 
analyzed by EDS (Table 3). There was no significant difference between the Ca/P ratios 
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within the three regions or between the two size ranges of CDHA microspheres (n=10, 
p>0.05). The Ca/P atomic ratio of stoichiometric hydroxyapatite is 1.67. 
 
 
Figure 4. SEM images of cross section of 106-150 μm open CDHA microspheres (A) and 
212-250μm open CDHA microspheres (B). 
 
Table 3. Ca/P atomic ratio (n = 10; mean ± SD) for the three layers that constitute the 
walls of hollow CDHA microspheres. 
CDHA microspheres Cross-sectional zone Ca/P atomic ratio  
106-150 m 
Surface layer (A) 
Middle layer (B) 
Inner layer (C) 
1.63 ± 0.11 
1.63 ± 0.11 
1.60 ± 0.14 
212-250 m 
Surface layer (D) 
Middle layer (E) 
Inner layer (F) 
1.67 ± 0.10 
1.63 ± 0.08 
1.63 ± 0.06 
 
3.3. EVALUATION OF BONE REGENERATION IN RAT CALVARIAL 
DEFECTS  
H&E and von Kossa stained sections of the implants with closed and open hollow 
CDHA microspheres after 6 weeks in rat calvarial defects are shown in Figures 5 and 6. 










bone bridging along the bottom of implants. Fibrous tissues (light blue in H&E stained 
sections) filled the space between the microspheres. New bone formation in the implants 
with the smaller closed and open CDHA microspheres was 12 ± 3% and 17 ± 6%, 
respectively (Figure 5 and Table 4). The von Kossa positive areas in in the implants with 
the smaller closed and open CDHA microspheres were 41 ± 3% and 49 ± 5%, 
respectively (Table 5). The percentages of new bone in the implants with the larger 
closed and open CDHA microspheres were 6 ± 2 % and 12 ± 3%, respectively (Figure 6). 
The von Kossa positive areas in the implants with the larger size of closed and open 
CDHA microspheres were 30 ± 3% and 35 ± 3%, respectively. Open CDHA 
microspheres showed significant improvement in bone regeneration compared with 
closed CDHA microspheres for both size ranges at 6 weeks in rat calvarial defects (n = 5, 
p < 0.05 for both sizes, Figures 9 and 10). Smaller closed CDHA microspheres showed a 
significant increase in bone regeneration than the larger closed CDHA microspheres (n = 
5, p < 0.05). Based on the H&E results, there was a borderline difference in new bone 
formation between the two size ranges of open CDHA microspheres (n = 5, p = 0.050). 
However, based on von Kossa results, the smaller open CDHA microspheres showed a 
significant enhancement in bone growth compared to the larger open CDHA 
microspheres (n = 5, p < 0.001). 
Higher magnification images of the closed and open HA microspheres are shown 
in Figure 5C and D (from the boxed areas of Figure 5A1 and A2) and Figure 6C and D 
(from the boxed areas in Figure 6A1 and A2). For the closed HA microspheres with both 
size ranges, little bone formation was noted, fibrous tissue filled the pore spaces between 
the closed CDHA microspheres and infiltrated into the hollow cores of some broken 
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closed HA microspheres. In comparison, more bone regeneration was observed in the 
micro-concavity of open CDHA microspheres (indicated by blue arrows) in both sizes 
(ϕ106-150 μm and ϕ212-250 μm). 
The outcomes from the implants with the closed and open CDHA microspheres of 
the two size ranges after 12 weeks in rat calvarial defects are shown in Figures 7 and 8. 
New bone tissue formed from the edge of the defects and on the bottom of the implants. 
For the open CDHA microspheres, more new bone growth in the micro-concavities can 
be found; the remaining open CDHA microspheres can be observed in the new bone 
bridging the ends of defects. For the smaller closed and open CDHA microspheres 
(Figure 7), the percentages of new bone formation were 26 ± 8% and 49 ± 7%, 
respectively; the von Kossa positive areas were 55 ± 5% and 76 ± 4%, respectively. For 
the larger closed and open CDHA microspheres (Figure 8), the percentages of new bone 
were 30 ± 9% and 40 ± 8%, respectively; the von Kossa positive areas were 56 ± 5% and 
65 ± 5%, respectively. The open CDHA microspheres showed significant improvement 
in bone regeneration when compared to the closed CDHA microspheres, for both size 
ranges, after 12 weeks in rat calvarial defects (n = 5, p < 0.001 for small size; n = 5, p < 
0.05 for large size). There was no significant difference in new bone formation between 
the two size ranges for the closed CDHA microspheres (n = 5~10, p > 0.05). However, 
smaller open CDHA microspheres showed a more significant increase in bone 
regeneration than larger open CDHA microspheres (n = 5, p < 0.05). Bone regeneration 
was time-dependent for both size ranges; new bone formation increased significantly 
from 6 weeks to 12 weeks in rat calvarial defects (n = 5, p < 0.001 for closed CDHA 




Figure 5. H&E stained and von Kossa sections of implants composed of closed (A1, B1) 
and open (A2, B2) CDHA microspheres (ϕ106-150 μm) after 6 weeks in rat calvarial 
defects; (C, D) higher-magnification images of boxed area in (A1, A2). HB: host bone; 




Figure 6. H&E and von Kossa stained sections of implants composed of closed (A1, B1) 
and open (A2, B2) CDHA microspheres (ϕ212-250 μm) after 6 weeks in rat calvarial 
defects; (C, D) higher-magnification images of boxed area in (A1, A2). HB: host bone; 





Figure 7. H&E and von Kossa stained sections of implants composed of closed (A1, B1) 
and open (A2, B2) CDHA microspheres (ϕ106-150 μm) after 12 weeks in rat calvarial 
defects; (C, D) higher-magnification images of boxed area in (A1, A2). HB: host bone; 




Figure 8. H&E and von Kossa stained sections of implants composed of closed (A1, B1) 
and open (A2, B2) CDHA microspheres (ϕ212-250 μm) after 12 weeks in rat calvarial 
defects; (C, D) higher-magnification images of boxed area in (A1, A2). HB: host bone; 
NB: new bone. Blue arrow: new bone growth in micro-concavity. 
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Table 4. Comparative new bone formation in all implants after 6 or 12 weeks based on 
H&E staining. The amount of new bone is expressed as a percent of the total defect area 
(mean ± SD). 
CDHA microspheres 
New bone (%) 
6 weeks 12 weeks 
ϕ106-150 μm 
Closed 12 ± 3 26 ± 8 
Open 17 ± 6 49 ± 7 
ϕ212-250 μm 
Closed 6 ± 2 30 ± 9 
Open 12 ± 3 40 ± 8 
 
 
Figure 9. Comparative new bone formation in implants with closed and open CDHA 
microspheres with diameter of 106-150 μm or 212-250 μm after 6 weeks (6 W) and 12 
weeks (12 W) in rat calvarial defects (Mean ± SD; n = 5~10, * significant difference 





Figure 10. Comparative von Kossa positive area for implants of closed and open CDHA 
microspheres with diameter of 106-150 μm or 212-250 μm after 6 weeks (6 W) and 12 
weeks (12 W) in rat calvarial defects (Mean ± SD; n = 5~10, * significant difference 
between groups; p < 0.05). 
 
A comparison of closed and open HA microspheres in both sizes at 12 weeks is 
shown in higher magnified images in Figure 6C and D (from the boxed areas of Figure 
6A1 and A2) and Figure 7C and D (from the boxed areas of Figure 7A1 and A2). Bone 
regeneration in the cores of some broken closed CDHA microspheres was identified. A 
higher degree of new bone formation in the micro-concavity of open CDHA 




The ability of CDHA microspheres to regenerate bone can presumably be affected 
by the differences between closed and open CDHA microspheres in microstructure. In 
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this study, the microstructure of closed and open CDHA microspheres in two size ranges 
(ϕ106-150 μm vs. ϕ212-250 μm) were analyzed. To test CDHA microspheres in 
facilitating bone regeneration, rat calvarial defects were created and CDHA microspheres 
were implanted. Bone regeneration was evaluated in weeks 6 & 12. 
For both size ranges, the thickness of the denser (outer) layer was ~ 5 μm, while 
the ratio of the hollow core diameter to the microsphere diameter is ~0.6. The factors 
leading to these two distinct layers are still unclear. In the glass conversion process [17, 
22-24], ions are released from the soluble glass (i.e., Ca2+, Li+, B3+) to the aqueous 
phosphate solution. When the concentration of Ca2+ ions exceeds the local solubility 
limit, those ions react with phosphate anions solution to form calcium phosphate. As the 
glass dissolves, the calcium phosphate layer continues to thicken until the glass is 
completely converted to calcium phosphate. The kinetics and mechanism of the 
formation of the calcium phosphate layer in borate glass have been investigated in several 
studies [23, 25-27]. The conversion rate is initially described by a reaction-controlled 
model (linear kinetics); however, at the later stage, a three-dimensional diffusion model 
(parabolic kinetics) better explains the conversion rate. Presumably, the denser outer 
layer and porous inner layers result from these two kinetic models. Additional 
experiments can be set-up to further investigate the dynamic changes of SSA and pore 
size. 
The in vivo experiments showed that the open CDHA microspheres were effective 
in promoting bone formation. For both size ranges of the open CDHA microspheres, new 
bone formation was observed in both 6 weeks and 12 weeks post-implantation. The 
amount of new bone growth increased from 6 weeks to 12 weeks. In the study of 12-
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week implantation with small microspheres, new bone formation with the implants of 
open microsphere was about twice that of the closed microspheres; for large 
microspheres, new bone formation in the implants of open microspheres was about 30% 
higher than that of the closed microspheres. Thus, the open microspheres were more 
effective in facilitating bone regeneration than the closed microspheres. Compared to the 
closed microsphere, the open microsphere had a micro-concave region with a more 
porous and rougher surface (see Figures 1 and 2). These characters (i.e., micro-concavity, 
porosity, roughness) could contribute to the difference in bone regeneration between the 
closed and open microspheres. 
The effectiveness of micro-concave surfaces in promoting bone regeneration has 
been investigated by others [28-33]. For example, substantial mineralization was 
observed within the concavities, but not at the planar surfaces, of calcium phosphate 
ceramic discs in simulated body fluid, and smaller concavities (0.4 mm diameter) induced 
more mineralization than larger concavities (0.8 mm or 1.8 mm diameter) [32]. An in 
vivo study demonstrated that concavities stimulated the formation of blood vessels, a 
critical process for bone formation [33]. Stem cells showed better outcomes on a concave 
surface than a flat surface in terms of cell maturation, osteodifferentiation, and specific 
protein production [29]. Bone formation by intramembranous ossification was favored on 
a concave surface as well [31]. Concavity is also conducive to the accumulation of 
growth factors such as BMPs [28]. Differences in microstructure may also be a 
contributing factor to the outcome of bone regeneration. The internal concave surface 
was more porous and rougher compared to external convex surface (Figure 2).  
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The differences in porosity and roughness could influence dissolution/degradation 
of biomaterials, adsorption of growth factors, and mineral deposition from body fluids 
[34-41]. For instance, the degradation of a porous surface could lead to faster Ca2+ release 
which is a key factor in facilitating angiogenesis [42]. Further, a more porous and rougher 
surface could be a more suitable substrate for adsorption of biologically active molecules, 
such as BMPs and growth factors. Together, these lead to enhanced cell attachment, 
proliferation and differentiation.  
Dissolution/degradation rates of calcium phosphates have been shown to be 
affected by the ratio of Ca/P of the material [43-45]. For example, the dissolution rate of 
a calcium phosphate in water increased as the Ca/P ratio decreased [43]. Higher 
dissolution/degradation of HA could release more Ca2+ and phosphate ions, which could 
facilitate bone regeneration. It is possible that the Ca/P ratio of the CDHA can be 
manipulated to achieve varying degree of dissolution. In this study, there was no 
significant difference in Ca/P ratio within the three regions or between the two size 
ranges of CDHA microspheres. 
The current study demonstrated that the small open microspheres induced a more 
significant increase in bone regeneration than the large open microspheres at both 6 
weeks and 12 weeks. One reason for this difference may be attributed to the greater total 
surface area made available by the open microspheres for cell attachment. For equivalent 
masses of particles, there will be nearly twice as much available surface area for the open 
particles compared to the closed particles. Another reason for the difference in bone 
regeneration could be due to the inner surface curvature of the open microspheres. The 
small microspheres have higher curvature than the large microspheres. It remains to be 
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investigated how the curvature of the microspheres affect cellular physiology leading to 
the differential outcome of bone regeneration. 
An apparent observation is that new bone formation with implants of the small 
open microspheres was able to completely bridge the defects at the bottoms of all the 
implants (Figure 7). In comparison, few of the defects with closed microspheres were 
bridged. During the regeneration process, new bone formation started from the edge of 
the host bone and from the bottom of the defect (dura matter), where osteogenic cells and 
blood supply were abundant. The open microspheres might absorb the osteogenic factors 
by diffusion or fluid transport and trigger bone growth in the micro-concavity. The open 
microspheres at the bottom of the implants had the best chance of contact with the 
osteogenic factors not only from dura matter but also from the edges induced by the open 
microsphere in periphery.  
In the present study, the smaller (ϕ106-150 μm) open CDHA microspheres 
promoted more new bone formation than the larger open microspheres (ϕ212-250 μm) in 
rat calvarial defects. However, the optimum size of the open microspheres still needs to 
be determined. Furthermore, the open CDHA microspheres with high surface area could 
be applied as a device for protein/drug delivery and should be evaluated in future studies. 
Overall, this study demonstrated that open CDHA microspheres have better capacity to 
enhance bone formation than the closed CDHA microspheres, and their efficiency to 







The open CDHA microspheres significantly enhance bone regeneration compared 
to the closed CDHA microspheres at both 6 weeks and 12 weeks in rat calvarial defects. 
Compared with the larger size of open CDHA microspheres (smaller curvature), the 
smaller size of open CDHA microspheres (larger curvature) resulted in a more significant 
increase in bone regeneration. The differences in the microstructures of the CDHA 
microspheres (i.e., curvature, concavity, porosity, surface roughness, total surface area 
available for cell attachment) may deserve future attention.  
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II. HOLLOW BIPHASIC CALCIUM PHOSPHATE MICROSPHERES FROM 
GLASS DISSOLUTION AND REPRECIPITATION; PART I: PARTICLE 
FORMATION AND CHARACTERIZATION 
 
Youqu Shen1, Richard K. Brow1 
1Department of Materials Science and Engineering, Missouri University of Science and 
Technology Rolla, MO, 65409 
ABSTRACT 
Hollow biphasic calcium phosphate (BCP) microspheres have been prepared with 
different fractions of hydroxyapatite (HA) and β-tricalcium phosphate (β-TCP) and their 
in vitro reactivities determined. The microspheres were prepared by reacting soluble 
borate glasses in phosphate solutions (0.1 M or 0.25M K2HPO4) with different values of 
pH (7-12) to produce hollow calcium-deficient hydroxyapatite (CDHA) microspheres 
with Ca/P ratios that increased with solution pH. Heating the CDHA microspheres to 
800°C produced hollow, nanoporous BCP microspheres with ratios of nanocrystalline 
HA and β-TCP that correspond to the Ca/P ratio of the CDHA precursors. CDHA 
particles converted in pH=7 solutions (Ca/P≈1.55) and pH=12 solutions (Ca/P≈1.59) 
produced BCP microspheres with -TCP/HA=70/30 and -TCP/HA=44/56, respectively. 
The CDHA microspheres reacted more quickly in acetic acid than the BCP microspheres, 
and for the latter, those with a greater -TCP/HA ratio were more reactive. CDHA and 
BCP microspheres converted to nanocrystalline carbonated hydroxyapatite when 





Carbonated-hydroxyapatite, with the general formula (Ca, Na, Mg)10(PO4, HPO4, 
CO3)6(OH, Cl, F)2 [1-4], is the mineral phase in hard tissue. Because of their 
biocompatibility and bioactivity, synthetic calcium phosphate ceramics, including 
hydroxyapatite (HA, Ca10(PO4)6(OH)2) and -tricalcium phosphate (-TCP, Ca3(PO4)2) 
are widely used as biomedical implant materials [5]. 
 Synthetic HA is osteoconductive and produces no systemic toxicity or 
immunological reactions. However, HA has found limited use as an allograft or autograft 
implant material, principally because HA lacks the osteoinductivity and osteogenicity 
possessed by allografts or autografts [6-9]. In practice, mixing HA with osteogenic 
growth factors is often needed to achieve desirable bone regeneration [6-8]. Compared to 
HA, -TCP is both osteoconductive and osteoinductive, and due to its low interfacial 
energy with respect to apatite, it can provoke the precipitation of an apatite layer upon 
incubation in aqueous ionic solutions [10]. β-TCP cannot be precipitated from aqueous 
solutions; instead, it forms when other phases[11], like calcium deficient hydroxyapatite 
[12] or mixtures of materials like dicalcium phosphate anhydrous and CaO [13], are 
heated above about 800°C. β-TCP can also be prepared at relatively low temperatures 
(~150 °C) by precipitation in water-free mediums, such as ethylene glycol [14]. 
Calcium phosphate microspheres can be produced by reacting Ca-containing 
soluble borate glass microspheres in a phosphate solution. By varying the glass 
composition [15], solution pH value [16], solution chemistry [17-19], and temperature 
[17, 20], the compositions and structures of the calcium phosphate microspheres can be 
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modified. For example, by adjusting the solution pH, the glass conversion process can 
produce semi-crystalline forms of dicalcium phosphate dehydrate (DCPD, pH=4.4), 
dicalcium phosphate anhydride (DCPA, pH=5.5), and calcium-deficient hydroxyapatite 
(pH=9.2) [16]. 
The objective of the present study is to create hollow biphasic calcium phosphate 
microspheres with controlled degradation rates and to characterize their performance in 
vitro and in vivo. In Part I of this study, the glass conversion process used in previous 
studies to produce HA microspheres from CDHA microspheres with a range of Ca/P 
ratios is described, as is their conversion by heat treatments to hollow BCP microspheres 
with a range of β-TCP/HA ratios. Compositions and phase distributions were determined 
by analytical scanning electron microscopy, x-ray diffraction, and Raman spectroscopy.  
The relative reactivity of CDHA and BCP particles, in acetic acid and in simulated body 
fluid (SBF), is described.  In Part II [21], the results of in vivo implantations of CDHA 
and BCP microspheres in rat calvarial defects (8 weeks) and subcutaneous defects (8 and 
12 weeks) are described.  BCP microspheres with greater fractions of β-TCP were found 
to promote a greater fractions of new bone formation in the calvarial defects and new 
blood vessel formation in the subcutaneous defects than CDHA particles and BCP 




2. MATERIALS AND METHODS 
2.1. PREPARATION AND CHARACTERIZATION OF HOLLOW BIPHASIC 
CALCIUM PHOSPHATE MICROSPHERES 
A schematic diagram for making hollow CDHA and BCP microspheres is shown 
in Figure 1. 
 
 
Figure 1. Schematic diagram illustrating the formation of hollow calcium deficient 
hydroxyapatite microspheres and hollow biphasic calcium phosphate microspheres. 
 
Hollow CDHA microspheres were obtained by the glass conversion technique 
described in previous studies [17]. Briefly, a lithium-calcium- borate glass with the 
nominal composition  11Li2O, 15CaO, and 74B2O3 (wt%) was prepared by melting 
appropriate amounts of Li2CO3, CaCO3, and H3BO3 (Alfa Aesar, Haverhill, MA, USA) in 
a platinum crucible at 1200 °C for 45 min, then quenching the melt between stainless 
steel plates. Glass particles with sizes between 150 and 250 μm were obtained by 
grinding the glass in a shatter box and sieving through 60 and 100 mesh sieves. Glass 






800 °C  








at 1200 °C. The glass microspheres were reacted in K2HPO4 solutions (0.1 M or 0.25M) 
with pH values ranging between 7 and 12 at 37°C for 2-4 days, at a ratio of 1 g glass in 
200 ml phosphate solution, while stirring continuously.  The initial pH of the phosphate 
solution was set using appropriate amounts of HCl or NaOH. The converted 
microspheres were washed with distilled water and anhydrous ethanol, and then dried at 
room temperature for at least 12 h, and then at 90 °C for at least 12 h.  After conversion, 
some CDHA microspheres were converted to BCP microspheres by heating them in a 
platinum dish in air at 800°C for 5 hours.  
2.2. CHARACTERIZATION OF MICROSPHERES 
The microstructures of as-prepared and heat-treated microspheres were 
characterized by scanning electron microscopy (SEM) (S4700, Hitachi, Tokyo, Japan), at 
an accelerating voltage of 15 kV and working distance of 12.5 mm. Phase compositions 
were analyzed using X-ray diffraction (XRD) (PANalytical X’Pert Pro multi-purpose 
diffractometer). The XRD data were acquired in the 2θ range of 5-90° at a scanning 
speed of 2.8°/min using Cu K radiation (λ=0.15406 nm).  The diffraction data were 
compared with JCPDS cards of HA (01-076-0694) and β-TCP (01-070-2065), 
respectively. The weight fractions of HA and β-TCP in the heat-treated microspheres 
were estimated by matching the intensities of respective peaks with the intensity of each 
pure phase. The Ca/P ratios of the microspheres were determined by dissolving them in 
10% HNO3 solution and then measuring the respective concentrations of calcium and 
phosphorus using inductively-coupled optical emission spectroscopy (ICP-OES) (Avio 
200; Perkin Elmer, Waltham, MA).  
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Nitrogen absorption techniques (Surface Area & Pore Size Analyzer; NOVA 
2000e; Quantachrome, Boyton Beach, FL) were used to determine specific surface areas 
(SSA) of the microspheres (Brunauer-Emmett-Teller (BET) analyses) and the pore size 
distributions in their respective shell walls (Barrett-Joiner-Halenda (BJH) method). Three 
replicates for each group were measured and average values are reported.  
2.3. IN VITRO DEGRADATION BEHAVIOR OF CDHA AND BCP 
MICROSPHERES 
The aqueous degradation rates of microspheres were determined using two 
methods.  For the accelerated degradation tests, 15 mg of the microspheres were 
immersed in 50 ml of a potassium acetate acidic buffer (0.1M, pH=5.0) at 37 °C. Calcium 
and phosphorus concentrations in the solution were determined as a function of 
immersion time (0-3 days) using ICP-OES. In the second test, microspheres were 
immersed in SBF [22] with starting pH of 7.4 at 37 °C. Changes in microsphere mass and 
solution pH values were measured at various times.  Both tests were run in triplicate, and 
averages and standard deviations are reported. 
After 14-days of immersion in SBF solution, the microspheres were removed, 
washed gently using deionized water, dried, and analyzed using SEM, as described 
above.  The Raman spectra of the microspheres before and after SBF immersion were 
analyzed by µ-Raman spectrometer (ARAMIS; Horiba-Jobin Yvon, Inc.; Edison, NJ) 
using a He-Ne laser (632.8 nm).  Finally, these microspheres were analyzed by Fourier 
transform infrared (FTIR) spectroscopy (Nicolet iS50; Thermo Scientific; Madison, WI) 








Figure 2. SEM images of hollow microspheres produced in 0.25M K2HPO4 solution at 
pH=7 and 12, showing representative cross-sections (left), external surfaces (middle), and 





Figure 3. SEM images of hollow microspheres produced in 0.1M K2HPO4 solution at 
pH=7 and 12, showing representative cross-sections (left), external surfaces (middle), and 
internal surfaces (right). 
 
Micrographs of representative as-prepared and heat-treated microspheres, 
produced by conversion in 0.25 M and 0.1 M K2HPO4 solutions, are shown in Figures 2 
and 3, respectively. SEM images of the cross-sections indicate that the microspheres have 
porous shells and a hollow core. In general, the diameters of the hollow cores in 
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microspheres produced in 0.1 M K2HPO4 solution were larger than those of the 
microspheres produced in 0.25 M K2HPO4 solution. The diameter ratio of the hollow 
core (d) to the microspheres size (D) for microspheres produced in 0.1 M K2HPO4 
solution was in the range 0.52-0.54, whereas the d/D ratio was in the range 0.35-0.37 for 
the microspheres produced in 0.25 M K2HPO4 solution (Table 1).  
 
Table 1. The diameter ratio of the hollow core (d) to the outer surface (D) of the 
microspheres prepared under the conditions indicated, along with their average particle 















7 0.25 - 0.374 ± 0.011 133 ± 13 152.0 ± 2.0 13.1 ± 0.2 
7 0.25 800°C/5h 0.353 ± 0.013 530 ± 90 1.5 ± 0.2 7.7 ± 0.2 
12 0.25 - 0.371 ± 0.006 90 ± 13 137.2 ± 5 9.1 ± 0.1 
12 0.25 800°C/5h 0.363 ± 0.011 770 ± 294 0.6 ± 0.1 6.9 ± 0.2 
7 0.1 - 0.543 ± 0.007 113 ± 16 147.4 ± 1.4 14 ± 0.1 
7 0.1 800°C/5h 0.536 ± 0.011 365 ±130 3.6 ± 0.1 6.8 ± 0.6 
12 0.1 - 0.534 ± 0.013 84 ± 22 148.2 ± 2.3 13.3 ± 0.5 
12 0.1 800°C/5h 0.518 ± 0.016 748 ± 253 6.6 ± 0.2 6.2 ± 0.3 
 
The as-prepared microspheres appear to be composed of nanoparticles with nearly 
spherical morphologies, and the particle sizes of the heat-treated samples are greater than 
those of the “as-prepared” samples. Image J [23] was used to characterize the average 
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sizes of the particles that form the shell walls of the microspheres shown in Figures 2 and 
3, and those values are given in Table 1. In general, the particle sizes of the as-prepared 
microspheres were similar, ranging from about 80 to about 130 nm, whereas the particle 
sizes of the heat-treated microspheres were significantly larger, ranging from 365 to 770 
nm. 
The surface areas and average pore sizes of the microspheres decreased 
significantly after the heat treatments, as shown in Table 1. After heat-treatment, the 
surface areas of the microspheres produced in 0.25 M K2HPO4 solution were lower (0.6 
and 1.5 m2/g) than those produced in 0.1 M K2HPO4 solution (3.6 and 6.6 m
2/g). 
3.2. PHASE DISTRIBUTIONS AND COMPOSITIONS OF THE AS-PREPARED 
AND HEAT-TREATED MICROSPHERES 
 
 
Figure 4. XRD patterns from the (A) as-prepared and (B) heat-treated microspheres 
produced in 0.25M K2HPO4 solution at various pH values. 
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Figure 4 shows the XRD patterns of the as-prepared and heat-treated 
microspheres produced in 0.25 M KH2PO4 solutions. Similar patterns were collected 
from the particles prepared in 0.1 M KH2PO4 solutions. The broad peaks in the XRD 
patterns of the as-prepared microspheres may indicate that the material was poorly 
crystallized, or consisted of nanometer-sized crystals, or a combination of both. These 
patterns are typical for Ca-deficient hydroxyapatite (CDHA) [24, 25].The intensity of the 
peaks increased markedly for the heat-treated microspheres, presumably as the result of 
increased crystal fraction or crystal size. The XRD patterns of heat-treated microspheres 
indicated the presence of various weight ratios of hydroxyapatite (HA) and tricalcium 
phosphate (-TCP). The weight fractions of the two phases (-TCP and HA) in the heat-
treated microspheres produced in 0.25 M and 0.1 M K2HPO4 solutions are summarized in 
Table 2. For the heat-treated microspheres produced in 0.25 M K2HPO4 solution, the -
TCP/HA weight ratios varied from >99/1 at pH=7 to 49/51 at pH=12. For the heat-treated 
microspheres produced in 0.1 M K2HPO4 solution, the -TCP/HA ratios varied from 
70/30 at pH=7 to 44/56 at pH=12.  
The quantitative XRD data was used to estimate the Ca/P atomic ratios of heat-
treated microspheres from the relative fractions of -TCP (Ca/P=1.50) and HA 
(Ca/P=1.67), and is compared with the Ca/P ratios determined by ICP-OES on 
microspheres dissolved in nitric acid (Table 2). There is a good agreement between the 
two sets of measurements. 
Figure 5 shows the Ca/P values determined for as-prepared microspheres (ICP 
only) and heat-treated microspheres (ICP and XRD), prepared in 0.25M and 0.1 M 
KH2PO4 solutions at different values of pH. There are no significant differences in the 
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compositions of the respective as-prepared and heat-treated particles, and the Ca/P ratios 
for both sets of particles increases with increasing solution pH. 
 
Table 2. Fractions of HA and -TCP (wt%) and the Ca/P atomic ratios, from XRD and 
ICP, for heat-treated microspheres produced in 0.25 M and 0.1 M K2HPO4 solutions at 
various pH values. 
 
0.25 M 0.1 M 







pH=7 >99/1 1.50 1.51 ± 0.02 70/30 1.55 1.55 ± 0.01 
pH=7.5 86/14 1.52 1.51 ± 0.02 - - - 
pH=8 82/18 1.53 1.53 ± 0.01 56/44 1.57 1.57 ± 0.01 
pH=8.5 73/27 1.54 1.55 ± 0.02 - - - 
pH=9 70/30 1.55 1.56 ± 0.01 51/47 1.58 1.58 ± 0.01 
pH=10 65/35 1.56 1.57 ± 0.02 - -  
pH=11 - - - 46/54 1.59 1.58 ± 0.01 
pH=12 49/51 1.58 1.59 ± 0.01 44/56 1.59 1.58 ± 0.03 
 
Therefore, based on XRD and ICP-OES analysis, we can confirm that the as-
prepared microspheres produced by glass conversion technique are CDHA microspheres, 






Figure 5. Ca/P ratios of as-prepared and heat-treated microspheres produced in 0.25 M 
and 0.1 M K2HPO4 solutions measured by ICP-OES and estimated by XRD. 
 
3.3. IN VITRO DEGRADATION 
3.3.1. Ion Release Kinetics in Potassium Acetate Solutions.  KAc solution was 
chosen to evaluate the relative reactivities of the CDHA and BCP microspheres, 
following procedures similar to those reported elsewhere [18, 26]. The calcium and 
phosphate ions released to the KAc solution are shown in Figure 6 A and B, respectively. 
Similar release kinetics were observed for each of the four sets of microspheres 
evaluated, with faster ion release rates over the first ten hours of reaction, and slower 
release rates thereafter.  In general, the CDHA microspheres released phosphate anions at 
faster rates than their respective BCP microspheres, (Figure 6B), but the fastest Ca-
release occurred from the BCP/pH=7 microspheres (Figure 6A).  The Ca/P ion ratios, 
released to the KAc solutions, normalized to the initial Ca/P ratios in the respective 
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particles, are shown as a function of immersion time in Figure 6 C. If this ratio equals 1, 
then the particles dissolve congruently.  If the ratio is less than 1, then phosphate is 
preferentially released to the solution. This analysis indicates that the CDHA 
microspheres (pH=7 and pH=12) dissolve congruently, at least for the first 24 hours.  The 
BCP (pH=7) particles, have Ca/P release ratios lower than what would be expected from 
congruent dissolution. As discussed below, this can be explained by a faster dissolution 
of the -TCP phase (Ca/P=1.5) in these BCP particles than the HA phase (Ca/P=1.67). 
 
 
Figure 6. Time dependences of the release of (A) Ca and (B) P from different 
microspheres to the KAc solution. (C) The Ca/P ion ratios released from different 
microspheres to the KAc solutions. 
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3.3.2. Apatite Formation in Simulated Body Fluid.  The microspheres were 
immersed in SBF solution at 37°C for two weeks. The mass of each set of microspheres 
initially decreased, then increased over the course of the experiment (Figure 7), an 
indication of occurrence of some initial dissolution and subsequent precipitation 
processes. The pH of the SBF increased slightly, from 7.4 to ~7.6, over the two-week 
experiment (Figure B.3).  
 
 
Figure 7. Weight changes in SBF solution at 37°C of the microspheres produced in 0.1 M 
K2HPO4 solution.  
 
Scanning electron micrographs of the surfaces of microspheres before and after 
immersion in SBF solution are shown in Figure 8. After immersion, the surfaces of the 
grains that constitute the structures of BCP/pH=7 and BCP/pH=12 microspheres are 
covered by smaller (<100 nm) crystals and some of these smaller crystals have formed 
clusters. Smaller crystals appear to have also formed on the surfaces of the CDHA 
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microspheres immersed in SBF, although these changes in surface topologies are less 
obvious than they are for the BCP microspheres with their larger initial grain sizes.  
Figure 9A and B shows the FTIR spectra collected from the different sets of 
microspheres, before and after immersion in SBF. The absorption bands corresponding to 
PO4
3- groups were observed in all spectra at approximately 1000-1120 cm-1 (v3), 945-970 
cm-1 (v1), 550-600 cm
-1 (v4), and these are consistent with the presence of apatitic phases 
[27]. A peak ~875 cm-1 in the spectra from the CDHA samples is assigned to HPO4
2- 
groups in these materials.  The spectra of the CDHA samples also revealed the presence 
of water (or -OH) species, including the sharp peak ~3570 cm-1 due to isolated OH 
groups [27, 28],  and the board peaks in the ranges 1600-1700 cm-1 and 3200-3600 cm-1, 
assigned to various water vibrations [27].  The spectra from the CDHA particles also  
have peaks in the range 1420-1460 cm-1 that can be assigned to the v2 modes of CO3
2-  
[27], characteristic of the B type substitution of  phosphate anions by carbonate anions in 
carbonated hydroxyapatites. This carbonate component may have formed from 
atmospheric CO2 dissolved in phosphate solution during the glass conversion process. 
Heat treating the CDHA microspheres to create the BCP microspheres eliminates the 
carbonate from the -TCP/HA structures, along with the water and the HPO42- anions. 
The peaks at 974 cm-1  and 947 cm-1 assign to the phosphate mode transformed from the 
peak at 962 cm-1, which indicate the presence of -TCP [27].  After immersion in SBF 
solution, there is clear evidence for CO3
2- incorporation into the structures of all four sets 
of microspheres, CDHA and BCP, indicating the formation of possible B-site carbonate-




Figure 8. SEM images of the external surfaces of the microspheres produced in 0.1 M 
K2HPO4 solutions before (left) and after (right) two-weeks of immersion in SBF solution 

















































Figure 9. FTIR (A, B) and Raman (C, D) spectra of the microspheres before and after 
immersion in SBF solution for 14 days. CDHA/pH=7: (a) before and (b) after; 
BCP/pH=7: (c) before and (d) after; CDHA/pH=12: (e) before and (f) after; BCP/pH=12: 
(g) before and (h) after. 
 
Figure 9C and B shows the Raman spectra collected from CDHA spheres 
prepared at pH=7 and pH=12, before and after two weeks of immersion in SBF, and the 
related BCP microspheres, also before and after SBF immersion. The spectra from the 
































O stretching mode (v1) of PO4
3- species, whereas two peaks evident in the spectra from 
the BCP microspheres, at 948 cm-1 and 970 cm-1, are assigned to v1 stretching modes of 
the PO4
3- anions in -TCP [29-31]. Peaks in the ranges 570-625 cm-1 and 400-490 cm-1 
are attributed to the v4 and v2 modes of PO4
3-, respectively. The v4 and v2 vibrational 
modes of PO4
3- are well-separated in the spectrum for HA, whereas these two modes are 
less separated in the spectrum for -TCP [30]. The low intensity, asymmetric v3 
stretching mode is located in the 1000-1100 cm-1 range [32, 33]. 
The Raman spectra collected from the CDHA microspheres are similar to those 
collected from HA, whereas the Raman spectra from the BCP microspheres are a mixture 
of the characteristic spectra of HA and -TCP [30]. Moreover, the intensity of the 
characteristic peak of HA at 960-962 cm-1 is relatively lower than the characteristic peaks 
of -TCP at 948 cm-1 and 970 cm-1 for BCP microspheres with greater -TCP contents, 
(e.g., see the XRD data in Table 2), whereas the relative intensity of the characteristic 
peak of HA is greater than those for -TCP from BCP microspheres with lower contents 
of -TCP. 
After immersion of the BCP microspheres in SBF solution, there is an increase in 
the relative intensity of the characteristic Raman peak of HA at 960-962 cm-1, compared 
to the -TCP peak intensities at 948 cm-1 and 970 cm-1.  This might indicate that the -
TCP phase dissolved from the BCP microspheres, to reprecipitate as nanocrystalline HA. 
Finally, the low intensity peak at ~1070 cm-1, assigned to the v1 CO3
2- symmetric 
vibrational mode, provides some additional evidence for the presence of carbonate 





4.1. SYNTHESIS OF CDHA AND BCP MICROSPHERES 
The hollow calcium phosphate microspheres formed using the borate glass 
conversion technique are similar to those described in previous studies [17, 36, 37]. 
When the calcium ions released from the dissolving Li-Ca-borate glass exceed the local 
solubility limit, they react with phosphate anions in solution to form an insoluble CDHA 
phase that precipitates on the glass surface. As the glass further dissolves, the calcium 
ions react with phosphate anions that diffuse through the CDHA surface layer, causing 
that layer to thicken by growing inward towards the center of the microsphere.  When the 
glass is completely dissolved, a hollow CDHA microsphere will have formed if the initial 
CaO-content of the glass is low, as it was in the present study (20 mole%).  Filled CDHA 
microspheres form when the initial CaO-contents are greater; e.g., 40 wt%  [37].   
The compositions and morphologies of the CDHA microspheres in the present 
study depend on the pH and phosphate concentration of the conversion solution.  For 
example, the Ca/P ratio of the microspheres increases with increasing solution pH and 
with lower solution phosphate concentration (Figure 5). The relative diameter of the 
hollow core is greater for microspheres produced in solutions with lower phosphate 
concentrations (Table 1). 
Variations in CDHA composition can be understood by considering the effects of 
pH on phosphate speciation in solution. For example, the phosphate anion speciation 
equilibria at 25°C are given by   
𝐻3𝑃𝑂4 + 𝐻2𝑂
𝑝𝐾𝑎=2.21
↔      𝐻2𝑃𝑂4
− + 𝐻3𝑂






↔      𝐻𝑃𝑂4
2− + 𝐻3𝑂




↔       𝑃𝑂4
3− + 𝐻3𝑂
+                                     (3) 
These are the phosphate species that react with the Ca-ions released from the dissolving 
Li-Ca-borate glass to precipitate CDHA.  Speciation of phosphate anions in aqueous 
solutions depends on pH; H2PO4
- and HPO4
2- are the dominant anions in solutions with 
pH<10, and PO4
3- anions become increasingly significant in more alkaline solutions. 
Ignoring the incorporation of carbonate anions, CDHA has the general chemical formula 
Ca10-x(HPO4)x(PO4)6-x(OH)2-x. The fraction of HPO4
2- anions incorporated in the CDHA 









                                                    (4) 
From equation (3), for the pH range used in this study to prepare the CDHA 
microspheres, the fraction of HPO4
2- anions in solution decrease with increasing pH.  If 
the fraction of HPO4
2- incorporated into the CDHA (‘x’) depends on the concentration of 
HPO4
2- in the conversion solution, then from equation (4), the Ca/P ratio in the resulting 
CDHA should increase with increasing solution pH, as shown in Figure 5.  Similar 
effects of solution pH on the precipitation of Ca-phosphate phases have been reported in 
the literature [30, 38], where pure -TCP (Ca/P=1.5) could be obtained by precipitation 
reactions from solutions with pH ~7 and subsequent heat treatments, whereas BCP 
particles with increasing fractions of HA (Ca/P=1.67) were produced from particles 
precipitated under more basic conditions (pH ≥ 8), followed by heat treatments.  
The CDHA particles produced from the 0.25M KH2PO4 solutions generally had 
lower Ca/P ratios than those produced from the 0.1M KH2PO4 solutions, particularly at 
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the lower pH values (Figure 5). That might be due to the pH changes in the 0.25M 
KH2PO4 solutions caused by glass conversion were less than those in 0.1M KH2PO4 
solutions. Moreover, the saturation index (SI) of precipitated hydroxyapatite is affected 
by the phosphate concentration [39]. When SI>0, the precipitation occurs spontaneously. 
It is reported that SI increase as phosphate concentration and pH of the solution 
increase[39]. Therefore, at a certain pH of the solution, precipitation of CDHA is easier 
in higher concentrated phosphate solution than in lower concentrated phosphate solution. 
The relative diameters of the hollow cores in the microspheres produced in the 
0.25M KH2PO4 solutions are smaller than those in the microspheres produced in the 
0.1M KH2PO4 solutions (Table 1), consistent with a previous study [17]. The average 
size of the individual grains on the surfaces of the CDHA microspheres and the 
microsphere surface areas and nanopore sizes are similar. The lower phosphate 
concentration likely leads to slower growth of calcium phosphate nuclei which may result 
in more efficient packing of the calcium phosphate crystals. In addition, the nanoparticle 
size observed on the external surface of the microspheres decreased from pH=7 to pH=12 
for both concentrations of phosphate solutions (Table A.1). Based on some dissolution 
behavior studies of borate glass [40, 41], the dissolution rate of the glass was found to be 
pH-dependent. For binary Li-B glass, the glass dissolution rate decreased as the pH value 
of buffer solution increased from 4 to 10 [40]. For Na-Ca-B glass in pH=4, 7 and 10 
buffer solutions, the glass was found to dissolve faster in lower pH solutions [41]. We 
conjectured that the dissolution rate of our Li-Ca-B glass increased as the pH value 
decreased, which may lead to faster formation of calcium phosphate nuclei. In addition, 
the faster dissolution of the glass may provide a higher concentration of Ca2+. The higher 
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concentration of calcium and phosphate ions may accelerate the aggregation of initial 
amorphous calcium phosphate [11, 42], which may lead to a larger particle size of 
calcium phosphate. 
Heat-treatments have been used in previous studies of Ca-phosphate microspheres 
to increase their mechanical strength [36, 43], although the development of biphasic 
ceramic microspheres with different concentrations of -TCP and HA has not been 
previously described.  In the present study, heating the microspheres at 800 °C for 5 
hours clearly transformed the CDHA to -TCP and HA. FTIR spectra (Figure 10A and 
B) show the disappearance of HPO4
2- and CO3
2- species from the CDHA, and the 
appearance of characteristic peaks of -TCP after the heat treatment.  XRD (Figures 4 
and 5) confirmed the formation of crystalline HA and -TCP, with fractions that 
depended on the initial composition of the CDHA materials (Figure 5). 
 When heated above about 700°C, CDHA decomposes to stoichiometric 
compounds, the relative fractions of which depend on the starting Ca/P ratio [26, 44]: 
𝐶𝑎10−𝑥(𝐻𝑃𝑂4)𝑥(𝑃𝑂4)6−𝑥(𝑂𝐻)2−𝑥 → 
3𝑥𝛽 − 𝐶𝑎3(𝑃𝑂4)2 + (1 − 𝑥)𝐶𝑎10(𝑃𝑂4)6(𝑂𝐻)2 + 𝑥𝐻2𝑂                       (6) 
When x=1 (Ca/P=1.5), the decomposition of CDHA produces -TCP, when x=0, 
hydroxyapatite is produced, and when 0 < x <1 (1.5<[Ca/P]<1.67), BCP particles with 
mixtures of -TCP and HA are produced.  For example, CDHA particles with x=0.50, 
(Ca9.5(HPO4)0.5(PO4)5.5(OH)1.5), where Ca/P=1.58, will decompose to BCP particles with 
48 wt% TCP: 52 wt% HA.  Therefore, the ultimate composition of the BCP particles is 
tailored by controlling the pH of the phosphate solution used in the conversion process, 
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which controls the speciation of phosphate anions that react with the Ca-ions released 
from the glass, and so control the Ca/P ratio of the precipitated particles.   
The heat treatment not only leads to the development of the distribution of phases 
that constitute the microspheres, but also affects their microstructure. The surface areas of 
the microspheres decreased dramatically after the heat-treatment and the particle size in 
the external surface increased after heat treatment (Table 1). In addition, the average size 
of the particles that constitute the microstructures of the BCP microspheres increased 
with increasing HA content. 
4.2. IN VITRO DEGRADATION OF CDHA AND BCP MICROSPHERES 
The in vitro degradation of calcium phosphate is affected by the composition and 
microstructure (i.e. surface area, porosity, pore size) of the microspheres, and the 
composition and pH of the solution. In general, the solubility of calcium phosphates in 
aqueous solutions decreases in order -TCP (Ca/P=1.5, solubility at 37 °C, -
log(Ksp)=29.5) > CDHA (Ca/P=1.5~1.67, solubility at 37 °C, -log(Ksp) =~85.1)>HA 
(Ca/P=1.67, solubility at 37 °C, -log(Ksp)=116.8) [5]. The comparative solubility in 
acidic buffer increases in order: -TCP>CDHA>>HA [5]. A greater specific surface area 
(SSA) for a particle could lead to a greater dissolution rate. In this study, the SSA of the 
CDHA microspheres are significantly greater than those of the BCP microspheres (Table 
1).  
In the accelerated degradation test, the release profiles of the calcium and 
phosphate ions from the microspheres were determined (Figure 6). The differences 
between the respective release rates of calcium and phosphate ions can be related to the 
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different Ca/P ratios of the microspheres and their microstructures. Although the P-
release rates from the CDHA microspheres were generally greater than from the BCP 
microspheres, this might be understood from the much greater surface areas of the former 
particles (Table 1); normalized to surface area, the BCP particles are more reactive than 
the CDHA particles.  For the two different BCP particles tested in Figure 6, the ones with 
the greater -TCP/HA ratio (pH=7, 70/30) released Ca and phosphate species at a greater 
rate than the particles with the lower -TCP/HA ratio (pH=12, 44/56), consistent with 
what is reported about the relative solubility of -TCP and HA ratio [26, 45]. The initial 
normalized Ca/P ratio of ions released from the -TCP/HA=70/30 particles was lower 
than the normalized Ca/P ratios from the other particles, indicating that the -TCP phase 
was dissolving preferentially (Figure 6C).      
Apatite-formation is a criterion used to evaluate the in vitro bioactivity of implant 
materials [46].  When the microspheres were immersed in SBF solution, their masses at 
first decreased and then increased with immersion time (Figure 7). Calcium and 
phosphate ions released from the microspheres re-precipitated as nanocrystalline 
hydroxyapatite particles on the surfaces of the microspheres, as indicated in the SEM 
images in Figure 8. The FTIR spectra in Figure 9B are consistent with the formation of 
carbonate-substituted hydroxyapatite. For BCP microspheres, the changes in the relative 
intensities of characteristic Raman peak of HA at 960-962 cm-1 to the -TCP peak 
intensities at 948 cm-1 and 970 cm-1 after SBF immersion indicates the dissolution of -
TCP phase from the BCP microspheres and the reprecipitation of HA (Figure 9D). More 
apatite formation was observed on the surfaces of BCP microspheres with 70wt% -TCP 





This study demonstrated that hollow BCP microspheres could be produced by the 
heat-treatment of CDHA microspheres obtained by the glass conversion technique. The 
composition and microstructure of the microspheres was affected by the concentration 
and pH value of the phosphate solution in glass conversion process. Two sets of CDHA 
microspheres (Ca/P ≈ 1.55 and 1.59) and the corresponding BCP microspheres (-
TCP/HA=70/30 and 44/56were selected for further in vitro tests. The BCP microspheres 
with 70wt% -TCP showed faster degradation rates in acetic acid and converted more 
quickly to HA in simulated body fluids. The ability to tailor the composition, nano-
structure, and meso-structure of these microspheres by controlling the processing 
conditions to convert the Li-Ca-B glasses in phosphate solutions means that materials can 
be designed for specific biomedical applications that utilize the macro-porosity of the 
hollow microspheres, the nano-porosity of the shell walls, and the enhanced bio-activity 
of the BCP phases. 
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ABSTRACT 
Hollow Ca-deficient hydroxyapatite (CDHA) microspheres were prepared by a 
glass dissolution/reprecipitation reaction, and converted through heat-treatments to 
biphasic calcium phosphate (BCP) microspheres.  By varying the pH of the solution used 
to convert the glass to CDHA, BCP particles with different fractions of hydroxyapatite 
(HA) and tricalcium phosphate (β-TCP) could be prepared.  CDHA and BCP 
microspheres were implanted in rat calvarial defects and after 8 weeks, the BCP 
microspheres with a -TCP/HA ratio of 70/30 (by weight) promoted a greater fraction of 
new bone formation (33 ± 7%) compared to BCP microspheres with a -TCP/HA ratio of 
44/56 (20 ± 9%) and to the respective CDHA microspheres (17 ± 4%, 17 ± 5). Bone 
formation was not observed in the subcutaneous implants of any types of these 
microspheres, after 8 weeks and 12 weeks, and so the microspheres are not 
osteoinductive. However, the more reactive BCP microspheres (-TCP/HA=70/30) were 





Over the past several decades, calcium phosphate materials have been developed 
for clinical applications to promote regeneration in osteo-defects [1-3]. In particular, 
biphasic calcium phosphate (BCP) materials that combine hydroxyapatite (HA) and -
tricalcium phosphate (-TCP) phases have served as bone graft substitutes in orthopedics 
[4-7].   
In general, HA is poorly bioresorbable, whereas -TCP is more bioresorbable and 
can be replaced by new bone at faster rates [3, 6, 7]. Therefore, the chemical properties of 
BCP materials can be tailored by the relative concentrations of the individual phases [2, 
4, 6-8]. The Ca/P atomic ratios in BCP materials range from 1.5 for pure -TCP to 1.67 
for pure HA. BCP ceramics have been used to produce biocompatible scaffolds, where 
the level of bioactivity, bioresorbability, osteoconductivity, and osteoinductivity could be 
adjusted by varying the -TCP/HA ratio [4-7]. Various BCP products with different -
TCP/HA ratios have been evaluated in large number of studies, but there is no agreement 
on the optimal -TCP/HA ratio for clinical applications [6].   
Previous studies [9-11] have shown that the hollow HA microspheres alone have 
limited capacity for bone regeneration, likely because they were composed of chemically 
stable HA or CDHA. In Part I of this study [12], CDHA microspheres were produced by 
a glass conversion technique and hollow BCP microspheres with different -TCP/HA 
ratios were produced by heat-treating the CDHA microspheres. The composition and 
microstructure of the microspheres was affected by the concentration and pH value of the 
phosphate solution used in the glass conversion process. 
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The objective of the present paper is to characterize the in vivo performance of the 
hollow CDHA and BCP microspheres. CDHA microspheres with different Ca/P ratios 
produce BCP microspheres with different β-TCP/HA ratios.  The microspheres were 
implanted in rat calvarial defects for 8 weeks and subcutaneous defects for 8 and 12 
weeks, and their bioactive performances were evaluated.  
 
2. MATERIALS AND METHODS 
2.1. PREPARATION AND CHARACTERIZATION OF HOLLOW BIPHASIC 
CALCIUM PHOSPHATE MICROSPHERES 
The preparation of CDHA and BCP microspheres used here is described in Part I 
of this study [12]. Briefly, hollow CDHA microspheres were prepared by reacting glass 
microspheres (composition 11Li2O, 15CaO and 74B2O3 (wt%), 150- 250 μm in diameter) 
in 0.1 M K2HPO4 solutions with pH values of 7 and 12 at 37°C for 4 days.  The 
converted microspheres were washed with distilled water and anhydrous ethanol, and 
then dried at room temperature for at least 12 h, and at 90 °C for at least 12 h.  After 
conversion, some of the CDHA microspheres were converted to BCP microspheres by 
heating them in a platinum dish in air at 800°C for 5 hours.  
Table 1 lists the properties of the hollow microspheres used in this study. Samples 
prepared in a phosphate solution with a pH of 7 had Ca/P atomic ratios of 1.55 and after 
the heat treatment, converted to BCP microspheres with an β-TCP/HA ratio of 70/30 (by 
weight), whereas samples prepared in a phosphate solution with a pH of 12 had Ca/P 
atomic ratios of 1.59 and after the heat treatment, converted to BCP microspheres with a 
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β-TCP/HA ratio of 44/56. Prior to implantation, all microspheres were sterilized by 
immersing in anhydrous ethanol and then exposing them to ultraviolet light for 15 min. 
2.2. IN VIVO STUDIES OF CDHA AND BCP MICROSPHERES  
All animal use and care procedures were approved by the Missouri S&T 
Institutional Animal Care and Use Committee in compliance with the NIH Guide for 
Care and Use of Laboratory Animals (1985). Male Sprague-Dawley (SD) rats, three 
months old, were used. Before surgery, the animals were acclimated for two weeks to 
diet, water, and housing under a 12 h/12 h light/dark cycle. The rats were anesthetized 
with a combination of isoflurane and oxygen. The surgery area on each animal was 
shaved, scrubbed with 70% ethanol and iodine, and draped. Calvarial defects and 
subcutaneous defects were implanted with one of the four groups of microspheres 
described in the previous section. The microspheres were sterilized by immersing in 
anhydrous ethanol and then exposing them to ultraviolet light for 15 min, prior to 
implantation. 
2.2.1. Calvarial Defects.  For the calvarial defects, sterile instruments and aseptic 
techniques were used to create a 1 cm cranial skin incision in an anterior-to-posterior 
direction along the midline. The subcutaneous tissue, musculature and periosteum were 
dissected and reflected to expose the calvaria. Bilateral full thickness defects (4.6 mm in 
diameter) were created in the central area of each parietal bone using a saline-cooled 
trephine drill. The sites were constantly irrigated with sterile phosphate-buffered saline to 
prevent overheating of the bone margins and to remove the bone debris. Each defect was 
randomly implanted with 10 mg of microspheres from each group listed in Table 1. After 
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the implantation of the microspheres, one drop of Ringer’s solution was added to each 
defect. The periosteum and skin were repositioned and closed with wound clips. Each 
animal received an intramuscular injection of ~200 μl buprenorphine and ~200 μl 
penicillin post-surgery. All animals were monitored daily for the condition of the surgical 
wound, food intake, activity and clinical signs of infection. After 8 weeks, the animals 
were sacrificed by CO2 inhalation, and the calvarial defect sites with surrounding bone 
and soft tissue were harvested for subsequent evaluations. 
2.2.2. Subcutaneous Defects.  For the subcutaneous implants, the microspheres 
were implanted at random implant sites to remove any bias from a single rat. Each rat had 
four implant sites, two inferior to the shoulders and two superior to the hind legs. An 
incision approximately 2 cm in length was made completely through the dermal tissue 
perpendicular to the spine with a pair of SuperCut surgical scissors. Then, a skin retractor 
was gently inserted into the incision to create a pocket between the cutaneous tissue and 
the skeletal muscle. Each pocket was randomly implanted with 20 mg of the 
microspheres from each group listed in Table 1, and the skin was then closed with wound 
clips. All rats received the same post-surgery care and monitoring as those in the calvarial 
implantation study. At the predetermined time points (8 weeks or 12 weeks), the animals 
were sacrificed and the subcutaneous defect sites with surrounding soft tissue were 
harvested for subsequent evaluations. 
2.2.3. Histological Processing.  Harvested calvarial samples and subcutaneous 
samples were fixed in a 10% neutral buffer formalin solution for five days. All samples 
were cut in the middle after being washed with deionized water. The samples were 
decalcified in 14 wt% ethylenediaminetetraacetic acid (Sigma-Aldrich, USA) for 2 
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weeks, dehydrated in ethanol, and then embedded in paraffin using standard histological 
techniques. These samples were sectioned using a microtome (Leica RM 2235, 
Germany). The thickness of the tissue section with paraffin was 5 μm. These slices were 
then stained with hematoxylin and eosin (H&E).  
2.2.4. Histomorphometric Analysis.  The stained sections were viewed using an 
optical microscope (KH-8700, Hirox-USA) and analyzed by Image J software (National 
Institutes of Health, USA). 
For calvarial samples, the percentages of new bone and residual microspheres in 
the defect were evaluated from the H&E stained sections. The total defect area was 
measured from one edge of the old calvarial bone, including the entire implant and tissue 
within it, to the other edge of the old bone. The newly formed bone and residual 
microspheres within this area were then outlined and measured. The amount of the new 
bone formation and residual microspheres were expressed as a percentage of the total 
defect area. 
For subcutaneous samples, the blood vessels and foreign body giant cells were 
examined based on the H&E stained sections. The total defect area containing all the 
microspheres and tissue within them was identified, and blood vessels and foreign body 
giant cells were outlined, measured, and presented as a percentage of the total defect area.   
2.3. STATISTICAL ANALYSIS 
Measurements of the percentage of new bone or blood vessel formation (relative 
to the entire defect area) were expressed as a mean ± SD. Analysis for differences 
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between groups was performed using one-way analysis of variance (ANOVA) followed 
by the Tukey’s post hoc test; the differences were considered significant at p < 0.05.  
 
3. RESULTS 
3.1. HOLLOW CA-PHOSPHATE MICROSPHERES 
 
Figure 1. Electron micrographs of the cross-sections (left), external surfaces (center) and 




Table 1. Microspheres used for in vivo tests (rat calvarial implantation and subcutaneous 

















1 7 - CDHA ~1.55 147.4 ± 1.4 14 ± 0.1 6 
2 7 




~1.55 3.6 ± 0.1 6.8 ± 0.6 6 
3 12 - CDHA ~1.59 148.2 ± 2.3 148.2 ± 2.3 6 
4 12 




~1.59 6.6 ± 0.2 6.6 ± 0.2 6 
 
Figure 1 shows representative scanning electron microscopic images of the 
CDHA and BCP microspheres used in this study, and Table 1 lists some of their 
properties [12].  The diameter ratios of hollow core to outer surface were ~0.53.  Samples 
prepared in a phosphate solution with a pH of 7 had Ca/P atomic ratios of 1.55, and after 
the heat treatment, converted to BCP microspheres with an β-TCP/HA ratio of 70/30 (by 
weight), whereas samples prepared in a phosphate solution with a pH of 12 had Ca/P 
atomic ratios of 1.59, and after the heat treatment, converted to BCP microspheres with 
an β-TCP/HA ratio of 44/56.  The CDHA microspheres are formed from particles about 
100 nm in diameter [12] that form high surface areas (about 150 m2/g) with nanoporosity 
(Table 1).  After heat treatments, the CDHA particles transform to larger β-TCP and HA 
grains, and there is a substantial loss of surface area (4-7 m2/g), although the walls retain 
nanoporosity (Table 1). 
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3.2. CALVARIAL IMPLANTATION 
 
 
Figure 2. Optical images of H&E stained sections of rat calvarial defects implanted with 
four groups of microspheres at 8 weeks. (A1) CDHA/pH=7; (B1) BCP/pH=7; (C) 
CDHA/pH=12; (D) BCP/pH=12.  (A2-D2) Higher-magnification images of outlined 
areas in (A1-D1). HB=host bone; NB=new bone. 
 
H&E stained sections from the rat calvarial defects implanted with four groups of 
































formation and residual microspheres are summarized in Table 2. In general, the fractions 
of residual microspheres remaining increased in the order (BCP/pH=7) < (BCP/pH=12) < 
(CDHA/pH=7) = (CDHA/pH=12), whereas new bone formation increased in the opposite 
order (CDHA/pH=7) = (CDHA/pH=12) < (BCP/pH=12) < (BCP/pH=7).   
 
Table 2. Summary of areal fractions of new bone formation and residual microspheres in 
rat calvarial defects 8 weeks after implantation. 
Implant type Percent new bone (%) Percent residual microspheres (%) 
CDHA/pH=7 17 ± 4 31 ± 6 
BCP/pH=7 33 ± 7 23 ± 4 
CDHA/pH=12 17 ± 5 32 ± 6 
BCP/pH=12 20 ± 9 29 ± 3 
 
Figure 3A presents the data from Table 2 and shows that after eight weeks of 
implantation, the fraction of new bone formation associated with the BCP/pH=7 (70 wt% 
-TCP) microspheres was statistically greater than what formed around the other 
implants (n = 6, p < 0.05, Figure 3A).  For the CDHA microspheres and BCP/pH=12 (44 
wt% -TCP) microspheres, the new bone growth was limited to the periphery of the 
defects (edges and the bottom of the defects), and connective tissue filled the majority of 
these defects (Figure 2). There was no significant difference in new bone formation 




Figure 3. A comparison of A) new bone formation, and B) residual microspheres, as a 
percentage of the total defect area, in rat calvarial defects implanted with four group of 
microspheres at 8 weeks. (Mean ± SD; n = 6, * significant difference between groups; p < 
0.05). 
 
Figure 2 shows that residual microspheres remain in the calvarial defects after 
eight weeks implantation, and Figure 3B shows the respective cross-sectional areas of 
those microspheres. The areal fraction of residual BCP/pH=7 microspheres was 
significantly lower (n = 6, p < 0.05) than the residual fractions of the other three samples, 





of new bone formation around these particles. In fact, Figure 2B1 and B2 show that new 
bone or fibrous tissue has infiltrated into the hollow core of a number of the BCP/pH=7 
microspheres, additional evidence for the enhanced reactivity of these particles.  
3.3. SUBCUTANEOUS IMPLANTATION 
 
 
Figure 4. Optical images of H&E stained sections of rat subcutaneous defects implanted 
with four groups of microspheres at 8 weeks. (A) CDHA/pH=7; (B) BCP/pH=7; (C) 
CDHA/pH=12; (D) BCP/pH=12. Green arrows indicate multinuclear cells, yellow arrows 
indicate blood vessels. 
 
The H&E stained sections of subcutaneous defects implanted with the four groups 
of microspheres are shown in Figure 4 after implantation for 8 weeks and in Figure 5, 
after 12 weeks. No new bone formation was observed around any of these implants and 
so there is no evidence for osteoinductivity by these CDHA and BCP microspheres. Cell 
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nuclei are blue, cytoplasm connective tissue and extra cellular matrix are purple or red, 
and red blood cells are bright red. The microspheres from all four groups are surrounded 
by connective tissue, some giant multinuclear cells (green arrows) and blood vessels 
(yellow arrows). Larger numbers of blood vessels and giant multinuclear cells are 
associated with the BCP microspheres than with the associated CDHA microspheres. The 
biodegradation rates of the BCP microspheres appear to be faster than the CDHA 
microspheres. Moreover, the BCP/pH=7 microspheres appear to have degraded faster 
than BCP/pH=12 microspheres.  
 
 
Figure 5. Optical images of H&E stained sections of rat subcutaneous defects implanted 
with four groups of microspheres at 12 weeks. (A) CDHA/pH=7; (B) BCP/pH=7; (C) 
CDHA/pH=12; (D) BCP/pH=12. Green arrows indicate multinuclear cells, yellow arrows 
indicate blood vessels.  
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Table 3. Summary of the areal fractions of blood vessels and foreign body giant cells in 










0.41 ± 0.22 0.48 ± 0.21 8 
0.49 ± 0.17 0.16 ± 0.08 12 
BCP/pH=7 
1.27 ± 0.36 1.09 ± 0.35 8 
1.43 ± 0.38 0.69 ± 0.28 12 
CDHA/pH=12 
0.32 ± 0.13 0.29 ± 0.09 8 
0.64 ± 0.28 0.19 ± 0.05 12 
BCP/pH=12 
0.64 ± 0.16 0.78 ± 0.33 8 
0.79 ± 0.28 0.38 ± 0.20 12 
 
The percent area of blood vessels and foreign body giant cells in rat subcutaneous 
defects implanted for 8 weeks and 12 weeks with the microspheres from the four groups 
are summarized in Table 3. At 8 weeks, the areal fractions of blood vessels associated 
with the BCP microspheres are significantly enhanced relative to their respective CDHA 
microspheres (n = 6, p < 0.05, Figure 6A); the fraction of blood vessels formed in 
BCP/pH=7 microspheres was greater than those with the BCP/pH=12 microspheres, 
although the difference was not significant (n = 6, p > 0.05). After 12-weeks 
implantation, blood vessel formation increased for all groups compared to the 8-weeks 
implantation, although the increases were not significant (n = 6, p > 0.05). The area 
around the BCP/pH=7 microspheres had significantly more blood vessels than the areas 
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around the microspheres in other three groups (n = 6, p < 0.05). Furthermore, there was 
no significant difference in the formation of blood vessels between CDHA groups and 
BCP/pH=12 microspheres (n = 6, p > 0.05). 
 
 
Figure 6. Comparative areal fractions of blood vessels and foreign body giant cells in 
implants with the four groups of microspheres after 8 weeks and 12 weeks in rat 







Figure 6B shows that after eight weeks in the sub-cutaneous implants, the areal 
fractions of foreign body giant cells associated with the BCP microspheres were 
significantly greater than those associated with their respective CDHA microspheres (n = 
6, p < 0.05). There was no significant difference in the presence of foreign body giant 
cells between the two BCP groups, and no significant difference between the two CDHA 
groups, as well. The fractions of foreign body giant cells decreased between 8 weeks and 
12 weeks for all four groups, significantly for the CDHA/pH=7 and BCP/pH=12 
microspheres.  Additionally, the foreign body giant cells associated with the BCP/pH=7 
microspheres were significantly greater than those associated with the other three groups. 
 
4. DISCUSSION 
4.1. IN VIVO DEGRADATION 
The response of a body to the implantation of calcium phosphate materials 
includes the diffusion of biological fluid and then cellular colonization. The cells for 
bioresorption include monocytes, macrophages, giant cells, osteoclasts, and fibroblast, 
and the cells for tissue repair include osteogenic cells [2, 4, 13]. Therefore, for the in vivo 
studies, cell-mediated degradation also needs to be considered.  The chemical properties 
of calcium phosphate materials, such as solubility, influence the bioresorption ability. For 
BCP, the resorption activity is influenced by the ratio of -TCP/HA [4, 5, 14]. In general, 
the greater the ratio of -TCP/HA, the greater the bioresorption ability. This was 
confirmed in Part 1 of this study, where it was shown that the BCP microspheres with 70 
wt% -TCP dissolved faster in an acetic acid solution than the BCP microspheres with 44 
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wt% -TCP, and both dissolved faster than the respective CDHA microspheres, despite 
the much greater surface areas of the latter [12].  The bioresorption of the calcium 
phosphate is mainly regulated by osteoclasts in calvarial defects and macrophages in 
subcutaneous defects. The osteoclasts, a type of bone cell, are involved in the 
maintenance, repair and remodeling of the skeleton. These cells are able to release small 
amounts of hydrochloric acid at material surfaces leading to a local pH change and the 
dissolution of calcium phosphate [15].    
In the in vivo studies, in both the calvarial defects and subcutaneous defects, it is 
clear that the BCP microspheres with 70 wt% -TCP degraded faster than the other 
groups of microspheres (Figures 2, 4 and 5). For example, the residual fraction of 
microspheres in the calvarial defects implanted with BCP microspheres with 70 wt% -
TCP was significantly lower than those of other groups (Figure 3B). In the subcutaneous 
defects, there was a greater number of foreign body giant cells associated with the same 
group of BCP microspheres with 70 wt% -TCP (Figure 6B). The foreign body giant 
cells are a collection of fused macrophages that respond to the biomaterials [16]. The 
macrophages fused together to form giant cells at the biomaterial interface to digest the 
microspheres.  
4.2. BONE REGENERATION IN VIVO 
4.2.1. Bone Regeneration in Calvarial Defects.  The great interest in the use of 
BCP (-TCP/HA) materials for bone regeneration is based on the preferential dissolution 
of the -TCP phase. By adjusting the -TCP/HA ratio, the resorption rate of the implant, 
and its replacement by new bone, can be controlled [6, 7]. In the present study, bone 
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regeneration in calvarial defects implanted with BCP and CDHA microspheres were 
evaluated after 8 weeks. The BCP microspheres with 70 wt% -TCP significantly 
enhanced new bone formation compared with BCP microspheres with 44 wt% -TCP, 
and with the CDHA microspheres. 
 As mentioned before, the BCP microspheres with 70 wt% -TCP degraded faster 
in the animals, releasing more Ca and phosphate ions. Those ions may trigger the 
osteogenic differentiation and participate in new bone formation. For example, the 
release of calcium ions could affect the osteoblast viability, proliferation and 
differentiation [17]. The osteoblastic differentiation of mesenchymal stem cells (MSCs) 
is accompanied by the expression of calcium ion binding proteins and the incorporation 
of calcium ions into the extracellular matrix [18]. Moreover, the phosphate ions act as a 
specific signal affecting various gene expressions implicated in skeletal cell proliferation, 
differentiation, mineralization, and apoptosis [19]. In addition, with faster degradation, 
the BCP microspheres with 70 wt% -TCP provided more available space for the 
infiltration of cells and new bone formation.  
Furthermore, the surface roughness of the microspheres might be a factor for bone 
regeneration. Compared to the CDHA microspheres with smooth external surfaces, the 
surfaces of BCP microspheres were topologically rougher (Figure 1). A rougher surface 
could be a more suitable substrate for cell attachment, proliferation and differentiation.   
4.2.2. No Bone Regeneration in Subcutaneous Defects.  The microspheres were 
implanted in subcutaneous defects for 8 weeks and 12 weeks and there were no signs of 
new bone formation associated with any of these samples. In the literature, BCP materials 
have shown potential for osteoinductivity, however, not all BCP products can produce 
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new bone formation in non-osseous defects [6]. The osteoinduction phenomenon of BCPs 
is affected on the animal species. The observation of osteoinduction has been frequently 
reported in large animals[20-24], such as goats, pigs, dogs, while rarely in small animals 
[24-26], such as rabbits, mice, and rats until 120 days. Our microspheres of BCP or 
CDHA did not induce any new bone in the rat subcutaneous defects within 12 weeks. 
This is accordance with the previous in vivo studies using rats [24, 27]. 
4.3. BLOOD VESSEL FORMATION IN SUBCUTANEOUS DEFECTS 
For subcutaneous implantation, blood vessel formation increased between 8 
weeks and 12 weeks for all groups of microspheres, and more blood vessels were formed 
in the defects implanted with BCP microspheres than CDHA microspheres (Figure 6A). 
BCP microspheres with faster degradation rates could provide more calcium ions, which 
play an important role in angiogenesis [28]. The BCP microspheres were also associated 
with greater inflammation, where multinucleated giant cells fused from macrophages 
could secrete vascular endothelial factor (VEGF), an important element in the 
development and maintenance of vascularization [29, 30]. Together, these could enhance 
blood vessel formation in subcutaneous defects implanted with BCP microspheres. 
Vascularization induced by implanted biomaterials is a key factor for tissue 
repair, where blood flow supplies sufficient nutrition and growth factors needed for tissue 
repair. Angiogenesis and osteogenesis are intimately linked, and it has been suggested 
that both processes need to be properly regulated for bone regeneration [31-35]. Thus, 
BCP microspheres with enhanced ability to form blood vessels have the potential for 
bone and tissue regeneration. 
  
103 
4.4. INFLAMMATION IN THE SUBCUTANEOUS DEFECTS 
The properties of biomaterials, including surface properties, particle size, porosity 
and pore size, and the release of bioactive ions, could affect the functionality of immune 
cells [36]. The surface properties, such as wettability, charge, topography, and roughness 
will affect the adhesion of immune cells. Larger pore sizes in a biomaterial can enhance 
angiogenesis but inhibit inflammation. Some bioactive ions, such as calcium, have 
immunoregulatory effects. Calcium ions have been found to be involved in certain 
inflammatory signaling pathways. The upregulation and downregulation of inflammatory 
responses could be affected by the concentration of calcium ions [37, 38]. The immune 
cells not only could lead to inflammation, but also could release cytokines that regulate 
osteogenesis. Therefore, a favorable immune reaction creates an osteogenic 
microenvironment that can improve osteogenesis. However, an inappropriate immune 
reaction may lead to the chronic inflammation and the formation of a fibrous capsule 
around the biomaterials [36, 39].  
In this study, the BCP microspheres implanted in the subcutaneous defects 
induced stronger inflammatory response with foreign body giant cells than did the CDHA 
microspheres (Figure 6B). Moreover, the level of inflammatory response in all groups 
decreased between 8 weeks and 12 weeks (Figure 6B). Malard et al. [40] demonstrated 
that BCP particles with faster degradation rates led to better bone ingrowth and stronger 
inflammatory response. These results also suggest that the inflammatory response could 
be controlled by modifying the composition of the BCP particles. 
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4.5. POTENTIAL APPLICATIONS 
The BCP microspheres prepared in this study have some unusual properties 
compared to other BCP granules. The BCP microspheres are nanoporous [12], which 
should promote cell attachment and proliferation. When some part of the microsphere 
shell is resorbed, the hollow core is exposed, which could provide more available space 
for cell infiltration. The hollow BCP microspheres could also be used as devices for 
adsorption of proteins and drug delivery. For bone repair, the BCP microspheres could be 




Two sets of CDHA microspheres (Ca/P≈ 1.55 and 1.59) and the corresponding 
BCP microspheres (-TCP/HA =70/30 and 44/56) were implanted in both calvarial and 
subcutaneous sites. The BCP microspheres with 70 wt% -TCP showed faster 
degradation rates, and the ability to enhance new bone formation in rat calvarial defects, 
and to promote blood vessel formation in rat subcutaneous defects, compared to the other 
groups of microspheres.  
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ABSTRACT 
Scaffold architecture plays an important role in bone repair and there have been 
reports in the literature that the surface topology of an implant affects bone growth. 
Additive manufacturing techniques, like robocasting, allow the ready formation of 
complex scaffold architectures to optimize in vivo performance.  The objective of this 
study was to compare scaffolds of 13-93 glass, produced by the robocasting technique, 
with straight filaments scaffolds to those with curved filament to determine if the 
modified topology of the latter promotes greater bone formation in rat calvarial defects. 
Scaffolds with curved-filaments had slightly larger pores (150 ± 5 µm  70 ± 8 µm) and 
greater overall porosity (45 ± 3%) than scaffolds with straight filaments (155 ± 5 m 
diameter, pore dimensions of 117 ± 3 µm  75 ± 5 µm, porosity of 41 ± 2 %).  After six 
weeks in the calvarial defects, scaffolds with curved filaments stimulated a greater 
amount of new bone formation (30 ± 5%), than the straight filament scaffolds (25 ± 4%). 
Scaffolds that were pre-reacted to form thin (6 ± 1 µm) surface layers of hydroxyapatite, 
prior to implantation, were more effective at stimulating new bone formation, with the 
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curved-filament structures again showing significant improvement in new bone growth 




There is a growing need for the development of synthetic bone grafts to repair 
bone defects caused by injury and disease [1, 2]. For common tissue engineering 
strategies, biomaterial scaffolds for bone repair are required to serve as templates to guide 
the regeneration of new bone [3, 4]. An effective scaffold needs to mimic the structure 
and properties of natural bone [5]. In bone tissue engineering, the selection of materials 
and the architectural design of the scaffolds are important issues for clinical applications 
[3, 6].   
Bioactive glasses are widely used as scaffold materials for bone repair, due to 
their biocompatibility, osteoconductivity, their ability to form hydroxyapatite (HA) -like 
layers in vivo, and their ability to form a strong bond with the host bone. By adjusting the 
composition, a bioactive glass can release certain elements, such as boron [7], zinc [8, 9], 
copper [10, 11], and strontium [12], in a controlled manner that facilitates bone 
regeneration. Bioactive silicate glasses, including 45S5 [13, 14] and 13-93 [15-17], have 
been approved by the Food and Drug Administration (FDA) for in vivo use, and scaffolds 
based on these bioactive glasses can be fabricated with different architectures to provide 
desired mechanical and chemical environments for bone reconstruction.  
Additive manufacturing techniques provide opportunities for innovative design 
and fabrication of scaffold architectures [18], and many studies have been done to relate 
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different scaffold designs to bone formation, including the effects of porosity [19], pore 
size [20], filament concavity [21], mechanical properties [22], and so on.  
In our laboratory, porous bioactive glass scaffolds have been fabricated using 
different manufacturing techniques, their mechanical properties were tested in vitro, and 
their ability to support bone infiltration were tested in vivo [6, 23-27], including 13-93 
glass scaffolds with “trabecular” [24], “oriented” [24], or “grid-like” [27] microstructures 
to facilitate bone regeneration in rat calvarial defects. Among these three microstructures, 
the 13-93 glass scaffolds with grid-like (straight filament) structures showed the most 
promising bone formation results after shorter implantation times (6 weeks) [27]. 
Moreover, 13-93 glass scaffolds that were pre-reacted in a phosphate solution to form a 
thin hydroxyapatite (HA)-like surface layer on the filaments, prior to implantation, 
showed significantly enhanced bone regeneration in six weeks [27]. 
Rumpler et al [28] described curvature-driven effects that promoted in vivo tissue 
formation in scaffolds, particularly on concave surfaces, and Paris et al. [19] developed a 
scaffold curvature-mediated mechanism for the in vivo bio-mineralization of extra-
cellular matrix.  In a recent study [29, 30], we showed that open HA microspheres with 
rough, porous and concave surfaces were more effective at promoting new bone 
formation than did closed HA microspheres with smooth and convex surfaces. Based on 
these results, we hypothesized that 13-93 glass scaffolds with curved filaments may have 
improved capability to regenerate bone in vivo.  
The objective of this study is to evaluate the capability of 13-93 glass scaffolds 
with curved filaments to facilitate bone formation in an osseous (rat calvarial) defect 
model. Scaffolds with either straight filaments or curved filaments were fabricated by the 
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robocasting method using 13-93 glass powders that were then sintered to densify the 
filaments and to form filament-filament bonds. Some scaffolds were pre-reacted in a 
phosphate solution to form a thin HA-like layer, prior to implantation.  
 
2. MATERIALS AND METHODS 
2.1. PREPARATION OF 13-93 GLASS SCAFFOLDS 
 








Scaffolds of 13-93 glass (6Na2O, 12K2O, 5MgO, 20CaO, 53SiO2, 4P2O5, wt%) 
with grid-like (straight filament) structures were prepared using a robocasting method, as 
described in our previous studies [10, 26, 27]. The scaffolds with concave filaments were 
designed by RoboCAD (Figure 1) and fabricated using the robocasting method, as well. 
Briefly, 13-93 glass was prepared by melting appropriate amounts of Na2CO3, 
K2CO3, MgCO3, CaCO3, SiO2, and NaH2PO42H2O in a platinum crucible at 1350 °C for 
2 hours, and then quenching the melt between two cold stainless-steel plates.  Glass 
particles with an average diameter of ~ 4 μm were obtained using an attrition mill and 
these particles were mixed with a 20 wt% aqueous Pluronic@F-127 solution to form a 
slurry (40 vol% glass particles). The slurry was then extruded in oil using a robocasting 
system (RoboCAD 3.0; 3-D Inks, Stillwater, OK) to form green-body, 3-D scaffolds. 
After printing, the scaffolds were dried at room temperature for 24 hours and then in an 
oven (~90 °C) at least overnight to remove any residual oil and water. The scaffolds were 
then heated at 0.5-2 °C /min in flowing oxygen to 600 °C for binder burnout and sintered 
in air at 700 °C for 1 hour to densify the glass filaments. The as-fabricated scaffolds were 
machined into thin discs (4.6 mm in diameter  1.5 mm), washed twice with deionized 
water and twice with ethanol, dried in air, and then sterilized by heating in air for 12 
hours at 250°C. 
2.2. SURFACE MODIFICATION OF 13-93 GLASS SCAFFOLDS 
Prior to the implantation, some of the as-fabricated scaffolds were reacted in an 
aqueous phosphate solution to produce a hydroxyapatite (HA)-like surface layer on the 
glass filaments, as described in previous studies [27, 31]. Briefly, the as-fabricated 13-93 
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glass scaffolds were immersed in 0.25 M K2HPO4 solution at 60 °C and pH = 12 
(adjusted with 2 M NaOH solution) for 3 days. The ratio of mass of glass scaffolds to the 
volume of the phosphate solution was kept at 1g per 200 ml, and the solution was stirred 
gently every day. After the conversion, the scaffolds were rinsed with deionized water 
twice and with ethanol twice. The scaffolds were dried at 4 °C for at least 48 hours before 
implantation.  The pre-treated scaffolds were sterilized by immersing them in anhydrous 
ethanol and then exposing them to ultraviolet light for 15 min, prior to implantation. 
2.3. ANIMAL EXPERIMENTS 
All animal use and care procedures were approved by the Missouri S&T 
Institutional Animal Care and Use Committee, in compliance with the NIH Guide for 
Care and Use of Laboratory Animals (1985). Four groups of scaffolds, described in Table 
1, were implanted in rat calvarial defects for 6 weeks. The implantation time was selected 
based upon our previous study [27] which showed considerable bone regeneration for 13-
93 glass scaffolds in the same animal model.  
 
Table 1. 13-93 glass scaffolds used in this study. 
Group Structure Pretreatment 
Number of defects 
(n) 
1 Straight - 7 
2 Curved - 7 
3 Straight Surface-modified 7 
4 Curved Surface-modified 7 
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Male Sprague-Dawley rats (3 months old, weight ~ 350 g, Envigo, USA) were 
acclimated for 2 weeks to diet, water, and housing under a 12 h/12 h light/dark cycle. The 
rats were anesthetized with a combination of ketamine and xylazine (0.15 μl per 100 g). 
The rat was shaved from the bridge of the snout to the caudal end of the skull using 
electric clippers, the shaved area scrubbed with 70% ethanol and iodine, and a sterile 
drape was placed over the body. With a sterile scalpel, a ~1.5 cm incision was made 
down to the periosteum over the scalp from the nasal bone to the middle sagittal crest or 
bregma. The subcutaneous tissue, musculature, and periosteum were separated to expose 
the calvaria. Bilateral full thickness defects (4.6 mm in diameter) were created in the 
central area of each parietal bone using a saline-cooled trephine drill. The sites were 
constantly irrigated with sterile PBS to prevent overheating of the bone margins and to 
remove the bone debris. The dura mater was poked to bleed a little bit, and a scaffold, 
randomly selected from one of the four groups listed in Table 1, was implanted into each 
defect. The periosteum and skin were repositioned and closed with wound clips, and each 
animal then received an intramuscular injection of ~200 μl buprenorphine and ~200 μl 
penicillin post-surgery. All animals were monitored daily for the condition of the surgical 
wound, food intake, activity, and clinical signs of infection. After 6 weeks, the animals 
were sacrificed by CO2 inhalation, and the calvarial defect sites with surrounding bone 
and soft tissue were harvested for subsequent evaluations. 
2.4. HISTOLOGICAL PROCESSING 
Harvested calvarial samples were fixed in a 10% formaldehyde solution for five 
days. The samples were cut into two halves after being washed with deionized water. One 
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half of each sample was used for paraffin embedding, and the other half was used for 
poly (methyl methacrylate) (PMMA) embedding. The paraffin-embedded samples were 
de-siliconized by immersing in 10% hydrofluoric acid for 2 hours, decalcified in 14 wt % 
ethylenediaminetetraacetic acid (EDTA, Sigma-Aldrich, USA) for 2 weeks, dehydrated 
in ethanol, and then embedded in paraffin using standard histological techniques. These 
samples were sectioned using a microtome. The thickness of the tissue section with 
paraffin was 5 μm. These slices were then stained with hematoxylin and eosin (H&E) 
[32] and Toluidine blue stain [33]. Without decalcification, the samples for PMMA 
embedding were dehydrated in ethanol and embedded in PMMA. These samples were 
sectioned, affixed to acrylic slices, and ground to a thickness down to 50 μm using a 
micro-grinding system (EXAKT 400CS, Norderstedt, Germany). The von Kossa stain 
was used to observe mineralization [34]. 
2.5. HISTOMORPHOMETRIC ANALYSIS 
Histomorphometric analysis was carried out using optical images of stained 
sections and Fiji software (National Institutes of Health, USA). The percentage of new 
bone formed in a calvarial defect was evaluated from the H&E stained sections. The total 
defect area was measured from one edge of the old calvarial bone, including the entire 
scaffold and tissue within it, to the other edge of the old bone. The available pore area 
within the scaffold was determined by removing the area of the scaffold from the total 
defect area.  The newly formed bone was identified by outlining the edge of the defect, 
with the presence of old and new bone being identified by lamellar and woven bone, 
respectively. The newly formed bone within this area was then outlined and measured; 
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the amount of the new bone was expressed as a percentage of the total defect area and the 
available pore area of the scaffolds. 
The Von Kossa positive area in the calvarial defects implanted with the scaffolds 
was determined from the von Kossa stained sections. The mineralized bone and the HA 
layer formed during glass conversion both reacted with silver nitrate to turn black in 
color.  These dark-stained areas in the defect images were outlined, measured by Fiji, and 
normalized to the total defect area. The positive area due to glass conversion was 
determined by subtracting the percentage of new bone in each sample from the 
percentage of von Kossa positive area in each sample. 
2.6. CHARACTERIZATION OF 13-93 GLASS SCAFFOLDS 
The scaffold porosity was determined using Archimedes method (ASTM C830). 
Briefly, the geometric volume of the scaffold (Vs) was computed by the dimensions 
measured by a Vernier caliper, while the volume of the glass content of the scaffold (Vg) 
was obtained by measuring the mass difference in air and in water. The porosity of the 
scaffold was derived from (Vs-Vg)/Vs×100.  Five as-fabricated scaffolds from each group 
were measured.  The as-fabricated 13-93 glass scaffolds with different structures were 
examined by optical microscopy (KH-8700, Hirox-USA). The microstructures of the as-
fabricated and surface-modified 13-93 glass scaffolds were observed using a scanning 
electron microscope (SEM; S4700 Hitachi, Tokyo, Japan) with an accelerating voltage of 
15kV and a working distance of 12 mm. The curvature of the concave region of the 
curved filament was measured by Fiji with Kappa plugin; 20 curves were randomly 
selected and measured. The unstained sections of the implants in PMMA were coated 
  
118 
with carbon and characterized using the SEM operating in the backscattered electron 
mode.  
2.7. STATISTICAL ANALYSIS 
Measurements of the percentage of new bone (relative to the entire defect area) 
were expressed as a mean ± SD. Analysis of differences between groups was performed 
using one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test; the 
differences were considered significant at p < 0.05.  
 
3. RESULTS 
3.1. MICROSTRUCTURE OF 13-93 GLASS SCAFFOLDS 
Optical images of the as-fabricated 13-93 glass scaffolds with straight and curved 
filaments are shown in Figure 2.  
For both types of scaffolds, the diameter of the glass filaments was 155 ± 5 µm. 
The straight filament scaffolds had pores that were 117 ± 3 µm wide in the plane of 
deposition (xy plane) and 75 ± 5 µm wide in the direction perpendicular to the deposition 
plane (z direction) (Figure 3A and B), with an overall porosity of 41 ± 2 %. The scaffolds 
with curved filaments had pores that were 150 ± 5 µm wide in the plane of deposition (xy 
plane) and 70 ± 8 µm in the direction perpendicular to the deposition plane (z direction) 
(Figure 3C and D), with an overall porosity of 45 ± 3%. The depth of the concave 
elements in the curved filament scaffolds was 105 ± 5 µm (h, in Figure 3D). The radius 




Figure 2. Optical images of 13-93 glass scaffolds ground into a disc shapes: A and B are 
a top-view and side view of the scaffold with straight filaments, respectively; C and D are 
a top-view and side-view of the scaffold with curved filaments, respectively. 
 
For the scaffolds with straight filaments, the angles at the intersection of two 
filaments is obviously ~ 90º. For the scaffold with curved filaments, there were a variety 
of the angles at the intersection of two filaments. An example from the center part of an 
as-fabricated scaffold with curved filaments is shown in Figure 4. Angles at these 










Figure 3. SEM images of as-fabricated 13-93 glass scaffolds with straight filaments (A) 
in the xy-plane, (B) in the z-direction; and with curved filaments (C) in the xy-plane, (D) 
in the z-direction. h indicates the depth of a concave element. 
 
 
Figure 4. Angles at intersection of two filaments in the center part of the as-fabricated 
scaffold with curved filaments. Red arrows: 40º -60º. Orange arrows: 60º -80º. Green 








Figure 5. SEM images of surface-modified 13-93 glass scaffold: (A) cross-section of 
converted scaffold filament and (B) surface of converted glass filament. 
 
Pre-treating scaffolds in a phosphate solution produced a thin (6 ± 1 µm) 
conversion layer on the surfaces of the glass filaments (Figure 5A), and these converted 
surfaces possessed both spherical nanoparticles and some needle-like nanoparticles 
(Figure 5B). These observations are consistent with previous studies of the formation of 
HA-like layers on the surfaces of 13-93 glass exposed to phosphate solutions [23, 24, 31, 
35].  
3.2. EVALUATION OF BONE REGENERATION IN RAT CALVARIAL 
DEFECTS 
Representative examples of the H&E stained sections from the four sets of 
implants after six weeks in the rat calvarial defects are shown in Figure 6. New bone 
formation was observed mainly at the edges of the defects (adjacent to the host bone) and 
along the dura mater/bottom of the defects, where blood vessels could provide more 
nutrients to the site. The amount of new bone growth, expressed as percentage of total 
defect area and available pore space in the scaffold, was dependent on the microstructure 







Figure 6. H&E stained sections of implants composed of as-fabricated 13-93 glass 
scaffold with straight (A1) or curved (B1) filaments, and surface-modified 13-93 glass 
scaffold with straight (C1) or curved (D1) filaments, from rat calvarial defects after 6 








Figure 7. H&E stained (A1-D1) and Toluidine blue stained (B2-D2) sections from the 
center part of the implants: (A1, A2) as-fabricated scaffold with straight filaments; (B1, 
B2) as-fabricated scaffold with curved filaments; (C1, C2) surface-modified scaffold with 
straight filaments; (D1, D2) surface-modified scaffold with curved filaments;. * indicates 
new bone. Yellow arrows indicate the accumulation of cells in the concave regions of the 
curved filaments and at the intersection of two filaments. Red arrows are similar sites 




























Table 2. Percent new bone formed and total von Kossa positive area in rat calverial 
defects implanted with the scaffolds at 6 weeks. 
Group 
New bone% Von Kossa positive % 
Total area Available area Total area 
1: straight 13 ± 3 25 ± 4 39 ± 4 
2: curved 18 ± 4 30 ± 5 44 ± 4 
3: pretreated straight 22 ± 6 40 ± 9 44 ± 5 
4: pretreated curved 32 ± 8 56 ± 13 49 ± 6 
 
H&E and Toluidine blue stained sections from the center parts of the implants for 
as-fabricated and surface-modified scaffolds are shown in Figure 7. For the as-fabricated 
scaffolds with straight filaments (Figure 7A1 and A2), accumulations of cells were found 
at the intersections of the filaments, and new bone appears to be growing from the 
intersections into the more open pore space. For the as-fabricated scaffold with curved 
filaments (Figure 7B1 and B2), accumulations of cells and bone growth were found at 
both filament intersections and in the concave regions of the filaments. For the surface-
modified scaffold with straight filaments (Figure 7C1 and C2), more bone formation was 
observed than in the as-fabricated scaffolds, and the accumulations of cells and bone 
maturation and remodeling were found at the filament intersections. For the surface-
modified scaffold with curved filaments (Figure 7D1 and D2), evidence for bone 
maturation and remodeling was observed in the scaffold pores, whereas newly formed 





Figure 8. Comparative new bone formation in rat calvarial defects implanted with 13-93 
glass scaffolds at 6 weeks: as-fabricated scaffold with straight filament; as-fabricated 
scaffolds with curved filaments; surface-modified scaffold with straight filaments; 
surface-modified scaffolds with curved filaments. The new bone formation is shown as a 
percent of available area in the scaffold. (Mean ± SD; n = 7, * significant difference 
between groups; p < 0.05). 
 
For as-fabricated 13-93 glass scaffolds, the percentages of new bone formation in 
the total defect area was 13 ± 3% for straight-filament scaffolds (Group 1) and 18 ± 4% 
for curved-filament scaffolds (Group 2). When normalized to the available pore space in 
the scaffolds, the amounts of new bone formation were 25 ± 4% and 30 ± 5% for 
scaffolds in Group 1 and Group 2, respectively. There was a statistically significant 
improvement in bone regeneration in the scaffolds with curved filaments compared with 
the scaffolds with straight filaments (n = 7, p < 0.05, Figure 8).  
For the surface-modified 13-93 glass scaffolds, values for new bone regeneration 
in the total defect areas were 22 ± 6% and 32 ± 8% for scaffolds with straight filaments 
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(Group 3) and curved filaments (Group 4), respectively. When normalized to the 
available pore space in the scaffolds, the percentages of new bone growth were 40 ± 9% 
and 56 ± 13% for Group 3 and Group 4, respectively. Again, for the surface-modified 13-
93 glass scaffolds, scaffolds with curved filaments showed statistically more new bone 
formation than scaffolds with straight filaments (n = 7, p < 0.05, Figure 8). 
For both the straight-filament and curved-filament designs, the pre-reacted 
scaffolds were more effective in promoting bone regeneration than the as-fabricated 
scaffolds (n = 7, p< 0.05, Figure 8).  
3.3. EVALUATION OF MINERALIZATION OF 13-93 GLASS SCAFFOLDS 
Representative examples of the Von Kossa stained sections of implants from the 
four sets of scaffolds are shown in Figure 9. A combination of mineralized bone and HA 
converted from the glass can be detected by von Kossa staining. The von Kossa positive 
areas (dark stain) are summarized in Table 2. The scaffolds with curved filaments showed 
significantly greater von Kossa positive areas than the scaffolds with straight filaments, 
for both as-fabricated and surface-modified scaffolds (n = 7, p < 0.05, Figure 10). For 
both the straight-filament and curved-filament designs, the pre-reacted scaffolds had 
significantly more von Kossa positive areas than the as-fabricated scaffolds (n = 7, p< 






Figure 9. Von Kossa stained sections of implants composed of as-fabricated 13-93 glass 
scaffold with straight (A) or curved (B) filaments or surface-modified 13-93 glass 
scaffold with straight (C) or curved (D) filaments, from rat calvarial defect after 6 weeks. 


































Figure 10. Comparative von Kossa positive areas for implants of 13-93 glass scaffolds in 
rat calvarial defects after 6 weeks: as-fabricated scaffolds with straight filaments; as-
fabricated scaffolds with curved filaments; surface-modified scaffolds with straight 
filaments; surface-modified scaffolds with curved filaments. The von Kossa positive 
areas are shown as a percent of available area in the scaffold. (Mean ± SD; n = 7, * 
significant difference between groups; p < 0.05). 
 
In order to evaluate the amount of von Kossa positive area that could be attributed 
to the formation of HA by the in vivo conversion of glass, the percent new bone 
determined from H&E staining (as a fraction of total available area) was subtracted from 
the percent von Kossa positive area. The von Kossa positive area due to HA formation by 
the in vivo conversion of the glass from Group 1 to Group 4 were 25 ± 5%, 25 ± 6%, 21 ± 
3% and 19 ± 6%, respectively. There was no significant difference in the von Kossa 





Figure 11. Backscatter SEM images of implants composed of as-fabricated 13-93 glass 
scaffolds with straight (A1) or curved (B1) filaments, or surface-modified 13-93 glass 
scaffold with straight (C1) or curved (D1) filaments, from rat calvarial defects after 6 






































Figure 11 shows backscatter SEM images of implants from the rat calvarial 
defects. The contrast in the grayscale images is an indication of differences in the calcium 
contents of the different areas including the glass scaffold, the converted surface layer, 
and the new bone [24, 30, 34]. Ca-rich areas are light gray, the silica-rich layer that forms 
on filaments in the early stage of glass conversion is dark gray, and lacunae and soft 
tissue regions are almost black. The glass filaments show three cross-sectional regions 
with different levels of grayscale: the inner-most region is unconverted glass, the middle 
region is the silica-rich layer, and the outermost region is the HA-like surface layer on the 
filament. For the as-fabricated scaffolds, the thickness of the HA-like surface layer in 
Group 1 (17 ± 2 m) was similar to that in Group 2 (17 ± 1 m). For the surface-
modified scaffolds, the thicknesses of the surface layers in Group 3 and Group 4 were 8 ± 
2 m and 7 ± 2 m, respectively, about one-half of the thicknesses of the layers that 




The reactions that occur at the surfaces of bioactive silicate glasses implanted in 
osteo-defects have been described by Hench [36] and updated by Gerhardt et al. [37], and 
are summarized in Table 3. Stages 1-3 involve the exchange of alkali and alkaline earth 
ions from the glass with protonated water (H3O
+) in the local environment to create a 
silica-rich surface layer.  An amorphous Ca-phosphate layer forms on the surface of the 
silica-rich layer when Ca2+ ions released from the glass react with phosphate and 
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carbonate anions in the physiological environment, and this layer then crystallizes to 
form carbonated hydroxyapatite (HCA) (Stages 4-5). Cells then attach, proliferate, and 
differentiate on the HCA surface (Stages 6-9), to generate extracellular matrix, crystallize 
inorganic hydroxyapatite, and form new bone (Stages 10-12). The progress of these 
reactions is determined by the composition and architecture of the glass scaffolds.  
 
Table 3. Sequence of interfacial reactions involved in forming a bond between bioactive 
glass and bone [36, 37]. 
Reaction events Stages 
Exchange of alkali ions with H3O
+ ions from body fluids 1 
Network dissolution and formation of silanol (SiOH) bonds 2 
Silca-gel polymerization: SiOH + SiOH → Si-O-Si 3 
Adsorption of amorphous Ca + PO4 + CO3 4 
Crystallization of HCA layer 5 
Biochemical adsorption of proteins (growth factors) on HCA layer 6 
Macrophages remove debris from site allowing cells to occupy the space 7 
Attachment of stem cells 8 
Differentiation of stem cells to form osteoblasts 9 
Generation of extracellular matrix 10 
Crystallization of inorganic calcium phosphate 11 




The in vivo experiments showed that the amount of bone regeneration after six 
weeks in rat calvarial defects depended on both the geometry of the 13-93 glass scaffold 
filaments, curved filaments were more effective than straight filaments, and the surface 
condition of the filaments where HA-converted filaments were more effective than the 
as-fabricated filaments (Figures 8 and 10).  In addition, new bone formation appears to be 
enhanced at filament-filament intersections and in the concave regions of the curved 
filaments (Figure 7). 
The influence of scaffold surface concavity on bone regeneration has been 
investigated in previous studies [38-43]. For example, the in vitro mineralization of 
calcium phosphate is enhanced in surface cavities (0.4 mm) compared to planar surfaces 
[38], and cell proliferation was enhanced on scaffolds with greater surface curvature [39]. 
Stem cells showed better maturation, osteo-differentiation, and specific protein 
production on a concave surface than a flat surface [40]. Both in vitro and in vivo studies 
[21, 28, 44, 45] have demonstrated that bone tissue growth is enhanced by surface 
curvature [28].  An in vivo test showed that concavities stimulated the formation of blood 
vessels which play an important role in bone regeneration [41]. Bone formation by 
intramembranous ossification was preferred on a concave surface [42], and concavity was 
shown to be conducive to the accumulation of growth factors, such as bone 
morphogenetic proteins (BMPs) [43]. Similar effects may contribute to the enhanced 
bone regeneration associated with the scaffolds formed from curved filaments compared 
to those with straight filaments, noted in the present study. 
Further, the pore size and overall porosity of scaffolds are important parameters 
for bone regeneration [46]. The pore size and porosity influence cell adhesion, 
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proliferation and distribution by affecting the access to cell recruitment, vascularization, 
nutrients and oxygen. Interconnected porous structures with pore sizes at least 100 µm 
have been recommended for scaffolds to regenerate bone due to cell size, migration 
requirements, and transport, and pore sizes > 300 µm lead to enhancement of new bone 
formation and vascularization  [46]. An in vivo test of dental implants coated with 
cancellous structured titanium showed that a slight increase in porosity (from 44% to 
48%) could increase the rate of new bone growth [47].  In the present study, the pore 
sizes of our scaffolds limited by the diameter of glass filament and robocasting technique 
are larger than 100 µm. Moreover, the scaffold with curved filaments had slightly greater 
overall porosity (45 ± 3%) and pore dimensions (150 ± 5 µm  70 ± 8 µm) than scaffolds 
with straight filaments (porosity = 41 ± 2 %, pore dimensions = 117 ± 3 µm  75 ± 5 
µm), and these differences might also contribute to the enhanced bone formation 
associated with the former structures.  
After 6-weeks implantation, an HA-like layer formed on the surfaces of the 
filaments that constituted the structures of each scaffold, as observed by the SEM images 
for both as-fabricated and surface-modified samples (Fig, 11). 13-93 glass is a bioactive 
silicate glass that reacts in vivo to initially form a silica-rich layer (Stages 1-3), on which 
an HA-like surface layer forms (Stages 4-5) [3, 15, 24, 48, 49]. For surface-modified 
scaffolds, no silica-rich layer was observed after the pretreatment (Figure 4A) due to the 
high solubility of silica at pH=12 [50], whereas a silica-rich layer was apparent (Figure 
12C1-2 and D1-2) after implantation in vivo. The thickness of the HA layer that formed 
in vivo on the as-fabricated scaffold was about twice that of the surface-modified 
scaffold.  The thickness of the HA layer in surface-modified scaffold did not change 
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much, from about 6 µm to 7-8 µm, after 6 weeks implantation in the rat calvarial defect. 
The thin HA-like layer obtained by pretreatment in phosphate solution could reduce the 
glass conversion rate in vivo [27], if that layer hinders the penetration of body fluids to 
react with the unconverted glass, or if the pre-treatment alters the glass chemistry at the 
glass-HA interface. 
The surface-modified scaffolds promoted greater levels of new bone formation 
compared to the as-fabricated scaffolds (Figure 8), consistent with a previous in vivo 
study of 13-93 glass scaffolds [27]. From that study, three points were raised. First, the 
HA layer on the surface of a glass scaffold obtained by pretreatment must interact with 
cells, tissues and some growth factors to promote bone formation [13, 23, 36, 51]. 
Second, when the as-fabricated scaffold initially reacts with the body fluid to form the 
silica-rich gel on the surface, this reaction could irreversibly denature proteins such as 
BMP-2 [13, 36, 51, 52]. Third, initial ion-exchange reactions at the glass surfaces 
increase the pH and osmolarity of the local physiological environment [48, 49, 53], and 
this could adversely affect cell viability and subsequent cellular and tissue interactions 
[54]. 
The in vivo results of the present work showed that the surface-modified scaffolds 
with curved filaments had a better capacity to facilitate new bone formation than 
scaffolds made with straight filaments, although differences in porosity and pore size 
between the two sets of scaffolds may also contribute to the enhanced bone regeneration. 
Pre-treating the scaffolds to produce a thin calcium phosphate layer on the glass surface 
improves the capability of the scaffold to support new bone formation. However, there 
are still some points that need to be investigated. For instance, the optimum fraction and 
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curvature of the concavities for bone regeneration are not known, nor is the optimum 




The geometry and surface condition of the filaments that constitute 13-93 glass 
scaffolds affect the generation of new bone after six weeks in rat calvarial defects.  
Scaffolds constructed from curved filaments exhibited enhanced bone regeneration 
compared to scaffolds made with straight filaments.  Pre-reacting the scaffolds to form 
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3.1. SUMMARY  
1) Open CDHA microspheres, produced by sectioning closed microspheres, promote 
greater new bone formation after six weeks and twelve weeks in rat calvarial defects 
then do the closed microspheres.  
2) Open CDHA microspheres with smaller radii (53-75 µm) promote greater new bone 
formation than open HA microspheres with larger radii (106-125 µm).  
3) Open and closed CDHA microspheres loaded with the same amount of BMP-2 (0.25 
μg per defect) promoted similar levels of new bone formation after six 6-weeks 
implantation in rat calvarial defects. 
4) Hollow BCP microspheres were produced by the heat-treatment of CDHA 
microspheres obtained by glass conversion technique. The composition and 
microstructure of the microspheres was affected by the concentration and pH value 
of the phosphate solution used in the glass conversion process.  
5) Two sets of CDHA microspheres (Ca/P ≈ 1.55 and 1.59) and the corresponding BCP 
microspheres (-TCP/HA =70/30 and 44/56) were selected for further in vitro tests. 
The BCP microspheres with 70 wt% -TCP showed faster reaction rates in acetic 
acid (pH=5) and simulated body fluid.  
6) Two sets of CDHA microspheres (Ca/P ≈ 1.55 and 1.59) and the corresponding 
BCP microspheres (-TCP/HA =70/30 and 44/56) were implanted in both calvarial 
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and subcutaneous sites in rats. The BCP microspheres with 70 wt% -TCP showed 
faster in vivo degradation rates, and the best ability to promote new bone formation 
in the calvarial defects, and to promote blood vessel formation in the subcutaneous 
defects, compared to the other groups of microspheres.  
7) The ability to tailor the composition, nano-structure, and meso-structure of these 
microspheres by controlling the processing conditions to convert the soluble Ca-
containing borate glasses in phosphate solutions means that materials can be designed 
for specific biomedical applications that utilize the macro-porosity of the hollow 
microspheres, the nano-porosity of the shell walls, and the enhanced bio-activity of 
the BCP phases. 
8) The geometry and surface condition of the filaments that constitute 13-93 glass 
scaffolds affect the generation of new bone after six weeks in rat calvarial defects.  
Scaffolds constructed from curved filaments exhibited enhanced new bone formation 
compared to scaffolds made with straight filaments.  Pre-reacting the scaffolds to 
form calcium phosphate surface layers also increased the capacity to promote new 
bone formation. 
3.2. RECOMMENDATIONS FOR FUTURE WORK 
3.2.1.  The Effect of Open CDHA Microspheres on Bone Regeneration.  Open 
CDHA microspheres can enhance bone formation compared to closed CDHA 
microspheres, and smaller open microspheres showed enhanced new bone formation 
compared with larger open microspheres.  The mechanism for this enhancement is not 
known and needs to be studied. The optimum open sphere radius has not been 
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determined; open spheres with radii smaller than 53 microns and larger than 125 microns 
should be studied to determine if there is a reproducible trend in microsphere radius on 
bone formation.  The enhanced bone formation associated with BCP particles compared 
to CDHA particles indicates that open BCP microspheres with large -TCP contents 
could be most effective for enhancing new bone formation. 
3.2.2.  Determine the Optimal Size of Open CDHA Microspheres and Dosage 
of BMP-2 for Bone Regeneration.  We do not know how BMP-2 is incorporated into 
the closed or open CDHA microspheres, whether it is only absorbed on the surfaces of 
the particles or in the nanoporosity of the particles. The optimal BMP-2 dosage has not 
been determined, nor have the release rates (pharmakinetics) from the particles.  This 
information must be acquired before treatments with BMP-2-loaded CDHA microspheres 
can be considered beyond these preliminary results. 
3.2.3.  Evaluation of BCP Microspheres in Bone Regeneration.  The 
compositions and microstructures of BCP particles are affected by the conditions of glass 
conversion and heat-treatment. The optimal design of BCP microspheres can be 
determined with more in vitro and in vivo experiments. The osteoinductivity of BCPs 
have been reported in other studies, but our BCP microspheres in current study did not 
show osteoinductivity in rat subcutaneous defects at up to 12 weeks. The osteoinductivity 
of BCP microspheres with modified compositions needs future investigation. The 
potential of BCP microspheres for protein delivery can be evaluated by loading some 
proteins, such as BSA, BMP-2, and then measuring release rates in standard solutions. 
3.2.4. 13-93 Glass Scaffolds with Curved Filaments for Bone Regeneration.  
The in vivo results of the present work showed that the surface-modified scaffolds with 
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curved filaments had a better capacity to facilitate new bone formation than scaffolds 
made with straight filaments. The optimum fraction and curvature of the concavities for 
bone regeneration is not known, nor is the optimum thickness of the pre-treatment layer. 
The scaffolds with larger fraction and curvature of curved filaments need to be fabricated 
for further in vivo tests. The effect of the fraction and curvature on the mechanical 
properties of the scaffolds also deserve further investigation by evaluating the 
















BONE REGENERATION FACILATED BY OPEN CDHA MICROSPEHRES 




Figure A.1. H&E and von Kossa stained sections of implants composed of closed (A1, 
B1) and open (A2, B2) CDHA microspheres without BMP-2 after 6 weeks in rat calvarial 
defects; (C, D) higher-magnification images of boxed area in (A1, A2). HB: host bone; 





Figure A.2. H&E stained and von Kossa sections of implants composed of closed and 
open hollow CDHA microspheres with BMP-2 after 6 weeks in rat calvarial defects: 
closed HA microspheres with 1 μg BMP-2 (A1, B1); open CDHA microspheres with 
0.25 μg BMP-2 (A2, B2); closed CDHA microspheres with 0.25 μg BMP-2 (A3, B3). 
HB: host bone; NB: new bone. 
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Table A.1. Comparative new bone formation and von Kossa positive area in all implants 
after 6 weeks in rat calvarial defects; the amount of new bone is expressed as a percent of 
the total defect area (mean ± SD). 
Hollow CDHA microspheres New bone (%) Positive area (%) 
Closed 6 ± 2 30 ± 3 
Open 12 ± 3 35 ± 3 
Closed + 1 μg BMP-2 40 ± 6 69 ± 5 
Closed + 0.25 μg BMP-2 26 ± 9 55 ± 8 
Open + 0.25 μg BMP-2 24 ± 8 49 ± 7 
 
 
Figure A.3. Comparative new bone formation in all implants after 6 weeks in rat calvarial 
defects. (Mean ± SD; n = 5~10, * significant difference between groups; p < 0.05). 
Closed CDHA microspheres denoted as “C”, open HA microspheres denoted as “O”, and 
closed CDHA microspheres loaded with 1 µg BMP-2/defect are control groups. All 





Figure A.4. Comparative von Kossa positive area for all implants after 6 weeks in rat 
calvarial defects. (Mean ± SD; n = 5~10, * significant difference between groups; p < 
0.05). Closed CDHA microspheres denoted as “C”, open CDHA microspheres denoted as 
“O”, and closed CDHA microspheres loaded with 1 µg BMP-2/defect are control groups. 








HOLLOW BIPHASIC CALCIUM PHOSPHATE MICROSPHERES FROM 




Table B.1. The particle sizes in the external surface and the diameter ratios of hollow 
core (d) to the microsphere size (D) of the microspheres produced in different conditions.  
Microspheres 
d/D Particle size (nm) 
pH K2HPO4 solution (M) Heat-treatment 
7 0.25 - 0.374 ± 0.011 133 ± 13 
7 0.25 800°C/5h 0.353 ± 0.013 530 ± 90 
9 0.25 - 0.370 ± 0.005 114 ± 10 
9 0.25 800°C/5h 0.351 ± 0.017 570 ± 113 
12 0.25 - 0.371 ± 0.006 90 ± 13 
12 0.25 800°C/5h 0.363 ± 0.011 770 ± 294 
7 0.1 - 0.543 ± 0.007 113 ± 16 
7 0.1 800°C/5h 0.536 ± 0.011 365 ±130 
9 0.1 - 0.546 ± 0.009 86 ± 10 
9 0.1 800°C/5h 0.532 ± 0.012 576 ± 244 
12 0.1 - 0.534 ± 0.013 84 ± 22 






Figure B.1. XRD patterns of the as-prepared (A) and heat-treated (B) microspheres 







Figure B.2. Percentage of calcium (A) and phosphate (B) ions released from the 
microspheres in KAc solution. (C) The Ca/P ion ratios released to the KAc solutions a 











Figure B.4. Changes of pH value of the SBF solution after adding the microspheres 





Figure B.5. SEM images of the external surfaces of the BCP microspheres: (A) 
BCP/pH=7 and (B) BCP/pH=12 after two-weeks of immersion of SBF solution at 37°C. 
 
 
Figure B.6. FTIR (A) and Raman (B) spectra of the microspheres before and after 
immersion in SBF solution for 14 days. CDHA/pH=7: (a) before and (b) after; 
BCP/pH=7: (c) before and (d) after; CDHA/pH=12: (e) before and (f) after; BCP/pH=12: 











Table B.2. Vibration modes observed in FTIR spectra of the microspheres before and 
after SBF solution. 
Vibration 
mode 
CDHA/pH=7 BCP/pH=7 CDHA/pH=12 BCP/pH=12 

































































































Figure B.7. XRD patterns of the CDHA and BCP microspheres produced at pH=7 (A) 













Figure C.1. Toluidine blue stained sections of implants composed of as-fabricated 13-93 
glass scaffolds with straight (A) or curved (B) filaments or surface-modified 13-93 glass 











Table C.1. Thickness of silica-rich layers measured from SEM images of implanted 
scaffolds (20 measurements). 
Group Thickness of silica-rich layer 
1 16 ± 4 
2 19 ± 6 
3 20 ± 7 
4 18 ± 5 
 
Table C.2. Ca/P atomic ratios in regions of the converted layer, the Si-rich layer, and 
unconverted glass from Von Kossa stained samples, assuming Ca2+ is replaced by 2Ag+. 
Group Converted layer Si-rich layer Unconverted glass 
1 1.59 ± 0.10 3.04 ± 0.35 5.68 ± 1.76 
2 1.63 ± 0.20 3.16 ± 0.41 5.79 ± 0.71 
3 1.55 ± 0.18 2.63 ± 0.31 5.48 ± 1.64 
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